{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Esther Wollert",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer’s disease",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/d9ec0526c20795146a9a6aef17496efe1a36cac6/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/c328ad964c08967a0417a887510b97b965a62fa5/external/mesh-names.belns"
    },
    "namespaces_uncached": [],
    "path": "nfkb/seo2017.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1\u0003, IL-6 and TNF-\u0005 are consequences of high A\u0003 levels [30,31].",
      "key": "69762da45d189ba432d222755fb6b12773d4c2dd8099f99ba3f76d6e11c602e6f5e4456d636df8ad0f0deea65b8242226d12c301df8b613593a9d48949e9ea3d",
      "line": 78,
      "relation": "increases",
      "source": 6,
      "target": 49
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1\u0003, IL-6 and TNF-\u0005 are consequences of high A\u0003 levels [30,31].",
      "key": "8d8311e573409e3e7fbe931c29e102e2e95c6ac69d4fd123a597410f336fd647d89c758a55cb3f7667f3092b0a16a09ca30a43cd318c662ebab1103ab08815aa",
      "line": 79,
      "relation": "increases",
      "source": 6,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1\u0003, IL-6 and TNF-\u0005 are consequences of high A\u0003 levels [30,31].",
      "key": "9a793b7a693e5cfccf270d35e1db6f8ef2f724b4529eace88d9d580c0fef5aebaba59910f0d502f68969e4e666b26fe1a5a3d91234b6016e2658d7e46cfbaa16",
      "line": 80,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1\u0003, IL-6 and TNF-\u0005 are consequences of high A\u0003 levels [30,31].",
      "key": "f23ce48f57b1e46e80353929d8dd0b07d0d61c488d2f486db66afafcf730c4f9af5fc0309879e2f6015e682eaf9f9953703824c9130e9d74cb041cae566d8af1",
      "line": 81,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 87
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glial activation, pro-inﬂammatory gene expression and elevated secretion of IL-1\u0003, IL-6 and TNF-\u0005 are consequences of high A\u0003 levels [30,31].",
      "key": "2b827d5792fe29345544099ebc0a4a68ddf166fa59c8a5327eb3bbd391f8e7502d871e9fe8558afce4e6b809eda0a138ef03a854984804738578a884ac5b308c",
      "line": 82,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 6,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, A\u0003 induced NF-\u0002B activity in glial and neuronal cells. NF-\u0002B is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "cd2778bb416a80e8fc8f0a8ac06d9991812f61527451197c5fe5b6a87385b9309611fe3d6b714bacf92ecae02ef0a35810072f41d3e62c574eab110ab1b3bc08",
      "line": 88,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 6,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, A\u0003 induced NF-\u0002B activity in glial and neuronal cells. NF-\u0002B is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "305945b9a01cff0db628af868c467bacaaa276e246c5c68bb0cdb3e8b940c65b1163b2f67d9f4b0c342da101d19b27d61f702b203b407c7b31f615692a3735b7",
      "line": 89,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 50,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of NF-\u0002B in TNF-\u0005 induced HepG2 cells [193].",
      "key": "8096ae42bf82e9bb837fc37a0442508250efea15d9963e9991a8cf8856f9fafa3f23d185e5bf44d4638a028594c16738d136defd06a47aa14c58814ad9582406",
      "line": 348,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 107,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "glial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, A\u0003 induced NF-\u0002B activity in glial and neuronal cells. NF-\u0002B is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "28fa228f21ce7a13be578e8206c75484da1f2fdfbae3db77572eaca2af86eeec15acaf7e8675c9b09562079548c18be44f61e1ca01df0feb7f53e3897e200e56",
      "line": 89,
      "relation": "association",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-\u0002B and the expression of pro-inﬂammatory genes [41].",
      "key": "3ae71deff3a0cd4a725bf4c51cfc63d2fcf26c150b493696c5351e68e0fb7d65fca0af396a31dc9e53c48d080f1c2a1ba88e36d2623396d7a96bb01af374c204",
      "line": 101,
      "relation": "increases",
      "source": 71,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "target": 50
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, A\u0003 induced NF-\u0002B activity in glial and neuronal cells. NF-\u0002B is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "48e55cdf06f34144c3a3150fb982aa5bc3482e52e981d97850fc785ef2791beca4386e293074d4072b9a82514a215f8b8d1f18266b1fc3155dedf4c90d48ccea",
      "line": 92,
      "relation": "positiveCorrelation",
      "source": 71,
      "target": 112
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Degeneration of neurons in the brain of AD patients is associated with the activation of NF-\u0002B [7",
      "key": "800b5fa75a6318a755e980717672129d29469942b9476fe99b015b423e619d9d09a0b9a45a2b3b2020975c8c4ec315d0f2c9afde7fea41087b9af44a654eb7bf",
      "line": 106,
      "relation": "association",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 111
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "NF-\u0002B activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-\u0002B activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "4c309e75191c0e8871b9ca95d4cb53e25a93aeb0543b946a3ec155495e7e2714f77e9116cf99cd9bef6fdf9e5d7713c19a82573e3598434ded0b930ab621597e",
      "line": 114,
      "relation": "regulates",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 61
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "NF-\u0002B activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-\u0002B activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "3f52489468600c6ddef6980945ad6d96376e8abcec44c75d31b58ec9d807dc01d930925613ea1419bc1477eb9d53f9067a1fb76a2ef9f1a00befda6f8091b8fb",
      "line": 115,
      "relation": "regulates",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "NF-\u0002B activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-\u0002B activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "08b5f126cbe59e4930d545bc7d20f708d495c90f5fd231d7f9d2f922bdc8f04927c06e9845bd7db8d7288d17e03fc78c78409e465bbc8e32648d6eb8ceef82af",
      "line": 116,
      "relation": "regulates",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 30
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "NF-\u0002B activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-\u0002B activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "025647bb4ed2d64e2cf9eb3af7c658c47e9ae41b632db1bbec3a8c8a31a8fe1c1f3c19f214f29bbeb8cf8a94b8e10654b4da515cbb404d938ed304b3eeb1a1c4",
      "line": 117,
      "relation": "regulates",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "NF-\u0002B activation mediates the expression of the pro-oxidant NAPDH oxidase, cyclooxygenase 2 (COX2), interleukins and the antioxidant enzyme, superoxide dismutase (SOD) [78]. Additionally, NF-\u0002B activity is associated with the expression of BACE1 [79] and the activation of nucleotide-binding oligomerization domain-like receptor (NALP) 3 inﬂammosome [80].",
      "key": "2e6fefe7900a0f6c16524629ed11349f6349a82f459e678d86260709671096d0ab7d05af9d374d953969bb4f0ae312075db5767e296e8a8a17a4858790cdc106",
      "line": 118,
      "relation": "increases",
      "source": 71,
      "subject": {
        "modifier": "Activity"
      },
      "target": 76
    },
    {
      "key": "c3ed49d060f417e2f057c0831964a1758b5c869497588bbf8d1a9fb7bc7c4a744791b10bf47d29cb516fd4c5c0e202f1f4a48de599c8ee225000e26a0efc3e15",
      "relation": "hasVariant",
      "source": 71,
      "target": 72
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, A\u0003 induced NF-\u0002B activity in glial and neuronal cells. NF-\u0002B is involved in inﬂammatory responses and is expressed in brains of AD patients [32].",
      "key": "a06809adeb4549ee5811e5b4c21d0fd95379d723d229f7174d9d8b74a1141baf80e30a5fa048ed50e872a4386c1a01f1c45e715e3a367c4493bd744e44fe3b89",
      "line": 92,
      "relation": "positiveCorrelation",
      "source": 112,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-\u0002B and the expression of pro-inﬂammatory genes [41].",
      "key": "f03f1685aaaab4bc91bc451fea630c9d7f5f23ecc6e3d572d84dc1ee0203ac8ac1cca320eff13093f6016db69cabd08635c299ceea526d1befd6c4933e57c2f3",
      "line": 98,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 73
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-\u0002B and the expression of pro-inﬂammatory genes [41].",
      "key": "e3be4caa582f8f649343619bc11fb158bb9bf56a49f10513858cd94dc77c74cdab6533aebfff741907a5d14adb1fb3088b78284a7a46fc43ab0507abee288463",
      "line": 99,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "ROS activate various downstream signaling molecules, such as PKC and mitogen-activated protein kinases (MAPKs) that induce nuclear translocation of NF-\u0002B and the expression of pro-inﬂammatory genes [41].",
      "key": "d1166b2687430310a03109c5ba18cc6c218530ba1cc1766dfa539d5f294a11d63e2983dc3b027026690c266d8a818d19b6164cb0c42c215f703587ce1d36ba5b",
      "line": 100,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 11,
      "target": 71
    },
    {
      "key": "bb0815ea687d7d2826ae28dc90dcc7e887f8b96a55fb690e506ecaf9a28aed1fda1e1b2e509336613c00249fbbc8b525939a8f8a053c9836e42b3009b7da31e5",
      "relation": "hasVariant",
      "source": 64,
      "target": 65
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Degeneration of neurons in the brain of AD patients is associated with the activation of NF-\u0002B [7",
      "key": "be00997067cc751c3e5e236b8004e7186e62c3acf91a687f27648a69a9539f5e0dc6ae9564c80341e9b3486286f1eaee0213bc4f9d2dffcffcb360da2cbc80eb",
      "line": 106,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 111,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "f463210996b052a07566e6362f198d3cf537257cee57ef8c18f2828104d0b42d2fa2669fc57cd5d02af235a2e4cc8c7568fa89ae9d334f94e356583adb7736d5",
      "line": 127,
      "relation": "decreases",
      "source": 18,
      "target": 50
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "5b49a1f68abbba0e88b75b94bfcb0bbd92adbed1c10a30d6468661de1d0ffeffee7a71340fcfceabf8fe75131365bd285c326f5dee601d3e190c57b8b1f8780f",
      "line": 128,
      "relation": "decreases",
      "source": 18,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "7805dbf2b8600f70022535d93c0f9b957d10a5a590adf19398ca3d9e99a0871835c60768e7523b5615fa998f4c66ee32e7e71adadd4424e7c32aea18ded64b78",
      "line": 129,
      "relation": "decreases",
      "source": 18,
      "target": 88
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "376395dcf82f35fe35f5e8d8000b0455ddd3b0f009964a2bb3ae12b618b75609fb5532f31893b51f5ae3bdd1e8e86bd79af7abed924bb3ff3e5a10f93055ab3e",
      "line": 130,
      "relation": "decreases",
      "source": 18,
      "target": 94
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "79544b9113b8abd5a016673871519e9fb8413ae514115a0721359a214e49109b9ce1399c532a979a3ed5773432b5af3b9ec8853b8d11cf4a371ff3fc4f86df6c",
      "line": 131,
      "relation": "decreases",
      "source": 18,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "9409fe85cee93e371593b4aa43db9fd693ba9ebb688ddbdb7e9f7d6aad9a9b927d688fa5c1f9d1425e4523cc268c66f34f4d53754877e38a59f49bbd401d645a",
      "line": 132,
      "relation": "decreases",
      "source": 18,
      "target": 84
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "74a959cf4f8d58dffc3a58e9a5dbaaff3ea625cfa73cff2aa00e5d3c58856b71b85688f5fba495176db5a8e3b133aea0f44c4d2a40bcbeadbbdb28be701eb5a5",
      "line": 133,
      "relation": "decreases",
      "source": 18,
      "target": 86
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "34650c59f0c8e0053fdb0635dfebe3570bd64ae68168c15a8a33368a590fe16aa2ccd234e6cf439bad0a90e7d2436677a6c8d36353caaefeb71dfc39021727a8",
      "line": 134,
      "relation": "decreases",
      "source": 18,
      "target": 87
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "8266ab7e221d330a9105a07b4b35c05baf90b38ef847ff0d8358a78409d6ebef1f22e25668764d9e858df77e6d2196abd9ea591f93ba809e01315e327da272e0",
      "line": 135,
      "relation": "decreases",
      "source": 18,
      "target": 78
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Curcumin showed several anti-inﬂammatory characteristics. It deploys various cytokine-inhibitory, anti-inﬂammatory activities and decreases the expression levels of COX-2, LOX, and iNOS. Moreover, the expression of the pro-inﬂammatory cytokines, for instance, TNF-\u0005, IL-1, -2,-6, -8, and -12 and the neurotoxic factors were suppressed by curcumin in lipopolysaccharide (LPS)-stimulated monocytes and alveolar macrophages [103].",
      "key": "4619bccf0a2b1d39f35e9b4852dbcbaeb6e008086feba32c4fe372779af90e2aeff8208658a6ae661fc346f7d7bcb590da45603391f81dac34f73f955ebef50b",
      "line": 136,
      "relation": "decreases",
      "source": 18,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-\u0002B pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of I\u0002B\u0005 and the nuclear translocation of NF-\u0002B p65 [106].",
      "key": "1bf4fc9c863b4444f40fe553d2d6294a43452101116f41234812b11fbe6ea4fd0ace3f37195401dc2ab064700f8ea298de5c316603641ded95d5073da9165b33",
      "line": 142,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 18,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-\u0002B pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of I\u0002B\u0005 and the nuclear translocation of NF-\u0002B p65 [106].",
      "key": "41fd238ed5d910b967359d16b4126293d318b6590f4fada48e7df33f4695f2cf7f650bba00d333d99390e3d3151682bd6006e226cc04b7dd312e133c291fc6f8",
      "line": 143,
      "relation": "decreases",
      "source": 18,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-\u0002B pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of I\u0002B\u0005 and the nuclear translocation of NF-\u0002B p65 [106].",
      "key": "f904bb642560e130f2d3c8197fb99886cfedcbe05545131e27e20779d1f53abc02cd35960da86969912366b83298da38c508205d661382dc217151e49429380a",
      "line": 144,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 18,
      "target": 92
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Inhibition of the NF-\u0002B pathway represents a well-deﬁned anti-inﬂammatory mechanism of curcumin[104,105]. Curcumin inhibited the phosphorylation and degrada-tion of I\u0002B\u0005 and the nuclear translocation of NF-\u0002B p65 [106].",
      "key": "380dca0f9f629bf1ed7e5a70ea19bc3056729c241942f8da82e8549ff6db2c160c87be99a8d635c8887141b670872a8b3bc394a18f8045628e717e6dabf1d5fd",
      "line": 145,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 18,
      "target": 98
    },
    {
      "key": "0ed6c6dac8c51cada38348203e50fb6cf7b85dd6c48b0ee3b9d652b7576c433b84b3d7f5a43c23fd24ef7517c84508fe2ff52091099026469a90613ab6778458",
      "relation": "hasVariant",
      "source": 92,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-\u0002B inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and \u0003 activiies [181,182]. ",
      "key": "8679e4e2b6480700035a7c2295bce7bdab5ddac4022d7c8ceaf26ba3ebe28b168005285e0b4cec87190131086678489bc4a6a6e416fc07ff3a502910f985c080",
      "line": 313,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 92,
      "target": 71
    },
    {
      "key": "773b1eefe15915e4c41f32b295fb47a7ac7685c7629f3325e46fca099dce7b4d05b9d79b163eb24b14e919d3d871a2def9e763049b93ce49509a508f20f5b983",
      "relation": "hasVariant",
      "source": 98,
      "target": 99
    },
    {
      "key": "3fcf9da549a1e7a9932a20769eafaaf5b64e9fa82b38b57bfa5734d49332c3ae8fb40859085e8f970f49a15de4df46fa920124a4ddee2238ca6b91cb996401b3",
      "relation": "hasVariant",
      "source": 98,
      "target": 100
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-\u0005, COX2 and interleukins [113,114].",
      "key": "845abbad2fe59ccbda591b4bcf4ecda6a9d8afa42cf5f8ba4ae0cc7532f3305fc3b2c0bef6a1c3d42129c8485ca2006128d5808300e3e91b3508370cf5b84c7c",
      "line": 150,
      "relation": "decreases",
      "source": 25,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-\u0005, COX2 and interleukins [113,114].",
      "key": "1d10c5d756b4b548aaa902e5a507e22e81df52dffbb4c35a809b8016d01cbedbc98c292fcf1e5567cbdb497af459778d1054e4a45c3f08ca0b1f2eb509503ae8",
      "line": 151,
      "relation": "decreases",
      "source": 25,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in A\u0003-activated glial cells. All these effects were attributableto their suppression of nuclear NF-\u0002B translocation [116].",
      "key": "9838702152746b183c8bdba894bbb5336349710477575da6f190e10d6b32828659ea09348a707e67f7c1dde45d0c01838ae8cdf8cfb46a0fdac2c9d441ef2d28",
      "line": 171,
      "relation": "decreases",
      "source": 25,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Resveratrol crossed the blood-brain barrier (BBB) [111,112] and down-regulated several inﬂammatory biomarkers such as TNF-\u0005, COX2 and interleukins [113,114].",
      "key": "4a8f2c4910eecf1ba4a0ede114c030355dd0aa1954d0df91a7b26d8ce5463b84880bee3724b16aa4c3ba19524d53f13d7524f1b456a2338ad70f8ca5fae9a787",
      "line": 152,
      "relation": "decreases",
      "source": 25,
      "target": 30
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and I\u0002B through LPS stimulation and subse-quently inhibited the activity of NF-\u0002B [115].",
      "key": "9011c52cb049a5dde25ab152048dc8f1d0630d6d2095a61ec48b1e8d273e2f680fa57124968777cf87e0f1ca9286e3119d8538490b1521f039787ba3809902a8",
      "line": 156,
      "relation": "decreases",
      "source": 25,
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and I\u0002B through LPS stimulation and subse-quently inhibited the activity of NF-\u0002B [115].",
      "key": "07f49be90b8c2ae05088e3d915d98ee4e847bbda38374ae0d1eced0115e93623809f8458ee31ecac78cfe9697b86c204e5f7d3f8414d453e61d76d03b0c13675",
      "line": 157,
      "relation": "decreases",
      "source": 25,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it decreased the phosphorylation of IKK and I\u0002B through LPS stimulation and subse-quently inhibited the activity of NF-\u0002B [115].",
      "key": "3e396260fdd500f2dbed4c76c18db65a61a0389ac775a7a601e1f151080acdfd31846f5f7e3f0d9179d8a481461c6fad72d7d981677b85fcfc3985c2589c0eba",
      "line": 158,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 25,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Resveratrol disrupted the phosphorylation of signal transducer and activator of transcription factor 1 (STAT1) and STAT3 [115].",
      "key": "146e72a59fb2675e389c89560f5b057439c7dc76e3580a667ff8a8d00a178bdd74aa9e93bd6dfa149b608a0be337af77aac4d008a4dfcc54c1ba665b117c804e",
      "line": 162,
      "relation": "decreases",
      "source": 25,
      "target": 102
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Resveratrol disrupted the phosphorylation of signal transducer and activator of transcription factor 1 (STAT1) and STAT3 [115].",
      "key": "854c84a88cbc0bc6356a4b9db86244d89702d87c57f5020b63a3ebe42132a6e6b420e4a21c83024383096ebe7500e1bb1b342b2bde294a363c4e60cfd78f1c97",
      "line": 163,
      "relation": "decreases",
      "source": 25,
      "target": 104
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in A\u0003-activated glial cells. All these effects were attributableto their suppression of nuclear NF-\u0002B translocation [116].",
      "key": "ebe6d369bbc3ad3a955f83d54b3a4b50b4b75400d3f42dcf5f0ae7ab0299627c0da63e89c9e77f584526cea2a87ef286accd9f6380baf7e5d8ad5b1a1b2ba5b6",
      "line": 168,
      "relation": "decreases",
      "source": 25,
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in A\u0003-activated glial cells. All these effects were attributableto their suppression of nuclear NF-\u0002B translocation [116].",
      "key": "b5dd6616a5524ca0c23dc0fdf5886dac6323ee3251aa61714efd036d98fbd142b414e9b5332e6fc03d0f174169a7f5405119cf6265364df49c2f264448037659",
      "line": 169,
      "relation": "decreases",
      "source": 25,
      "target": 94
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It also lowered the expression of NO and iNOS, and prostaglandin E2 (PGE2) and COX2 in A\u0003-activated glial cells. All these effects were attributableto their suppression of nuclear NF-\u0002B translocation [116].",
      "key": "0397abd70bcd0734f94f6117ae7abfd8a58d0f6ad4f67b2ce3c321ba97dd5cfe8612a307eef305dd9040345eb3557a205e9220fc6ab2bff42f1fde3025725510",
      "line": 170,
      "relation": "decreases",
      "source": 25,
      "target": 10
    },
    {
      "key": "930cdd32cee19cb856c4d5de22442f0a590e6dfa114a329b66ec61d2edd47fb40c3ac0b0c0c3657736ab312c1d09359f55a33d68f221be523da6de39bcfd9f82",
      "relation": "hasVariant",
      "source": 59,
      "target": 60
    },
    {
      "key": "2b9d2afda5bd965227e4ae577db075629040931d5159360d29cd0ac94d5c752c7b2706b61255bf7cbfadb96e67f61803cf240f81ca3b82e0227561e917fc4d5f",
      "relation": "hasVariant",
      "source": 101,
      "target": 102
    },
    {
      "key": "e39435c1348f217cc9cce7c925f90bd391da1bbc939ac4f4c08ca5c70e03100d1a8991a2f918452e95def9067c56d70330d08e862245632e0dbc00b78b74773a",
      "relation": "hasVariant",
      "source": 103,
      "target": 104
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR\u0005 regulation [118,119], NF-\u0002B transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "9a1601c4f09d40c341623122e7dc68a6b66c2cb8a70e6967eade178caa826ce78a06ec846143e94a38a6ba48890d13353892855df3f692c11b8fdce6f264a64f",
      "line": 176,
      "relation": "regulates",
      "source": 24,
      "target": 95
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR\u0005 regulation [118,119], NF-\u0002B transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "7d72d8ef8171c286f94b44b5c063a2aeb6dd982849c257939843ff15394bbdf0ff2962be822472684a7c3c50ffbbc3b244d4e06367df01cb541afd5564a7d923",
      "line": 177,
      "relation": "regulates",
      "source": 24,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It is even more potent than resveratrol through PPAR\u0005 regulation [118,119], NF-\u0002B transcription[120–122] and JNK phosphorylation [123,124].",
      "key": "b8cb3076ff7c201583c3dcb26bb7151c79f3ae1f3e78b5fab5f78150344f5e24596a01621a0030e21a0091871166bcbbe773162d48e3faa870777243049af4b9",
      "line": 178,
      "relation": "regulates",
      "source": 24,
      "target": 69
    },
    {
      "key": "17933e508d51db48f42ef35a908a9586a2a37a9dcec7203d400738956906f68d76a83da041475ddc1afe0db6c1d3b7f5e8d8f63861c3be3c70576651faeb6d99",
      "relation": "hasVariant",
      "source": 68,
      "target": 69
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Punicalagin decreased the expression of COX2 and DNA binding of NF-\u0002B in human colon cancer cell line [126].",
      "key": "ae8f1593465a8dda2407069f9285fab737e4aab58eeced51f246bf282c82423f3bfbac25f62ce3d7ae1ac2bba13b68eb147e436ce90f0be3f40183a2c07455ac",
      "line": 182,
      "relation": "decreases",
      "source": 42,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Punicalagin decreased the expression of COX2 and DNA binding of NF-\u0002B in human colon cancer cell line [126].",
      "key": "80cc8f22467fb79a945f104c68eb5f28dc488c6e18ff5c9d7bc26ed7db5f3a5432abac8c89c9c857af72099384a0a2d704efcec8507d1fc7a52ae48d3149ecbd",
      "line": 183,
      "relation": "decreases",
      "source": 42,
      "target": 57
    },
    {
      "annotations": {
        "Cell": {
          "astrocyte": true,
          "macrophage": true,
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Inﬂammation caused by LPS was reduced with treatment of punicalaginin RAW264.7 macrophages, astrocytes and microglial BV-2 cells",
      "key": "204b72885999f34663854551bdf62c4ec5f76bedb53cae1879b742a3cc22b31e76772e22a2c5d371e3afc7ffdbc1cd53bf4520eb5daa00a1e250e5cbf23694b6",
      "line": 188,
      "relation": "decreases",
      "source": 42,
      "target": 50
    },
    {
      "key": "391fad7482ffcea84fb5c41a0d0d16e43b9826963c0fad7fb112e722a82b1112ce3b1cedcec12ea205d5ff70f4e6e2f5e369a46a6446bbb57fd37ec6b09d231e",
      "relation": "hasComponent",
      "source": 57,
      "target": 29
    },
    {
      "key": "100258be645d72e71230e3a848deb5605a32e2f67a671785cc2d9a89efad32cf75469aed5c2d15fd0106d0b14a8d7900040fea4f0f664731072926c5bc040d82",
      "relation": "hasComponent",
      "source": 57,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-\u0002B pathway and activated the phosphorylation of I\u0002B\u0005, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "ead6544f5c18bad109374a91ffb3d30c8b9d4d6b6dd09da06289b384e8ef636aacfb5f268be638f7ca0ecfa61d3acf657b68cc5d637b0bb5ee4208cf1e2f3c98",
      "line": 193,
      "relation": "decreases",
      "source": 8,
      "target": 46
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-\u0002B pathway and activated the phosphorylation of I\u0002B\u0005, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "9d3fe9ced0014f6025463f6df7aa46999b1163c0e410b8164ce44b23c6d7ac205cdf9da5c8aa49b25011dfd083c7a06a092f3e6541fdb2dfe11bbf0518cb0c73",
      "line": 194,
      "relation": "increases",
      "source": 8,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-\u0002B pathway and activated the phosphorylation of I\u0002B\u0005, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "56ab4caad1db651cad7d7d2a32007079b498945829f613223b1e0afa40eff940a5ed0e64a0c221fc218d089bd011e859feea5fc23de26cd144156d00d49489f7",
      "line": 195,
      "relation": "increases",
      "source": 8,
      "target": 90
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Macranthoin G inhibited the NF-\u0002B pathway and activated the phosphorylation of I\u0002B\u0005, p38 and ERK, and thus, min-imized cell damage [131].",
      "key": "35d4bf8b7eed7a1aaf504aba738a343656fdbab32bb8dd932ae423687999267c7dc30359ed622cf189ddbe8c57880bc00fc47ca308a8da9c2f2b474e89a1ce96",
      "line": 196,
      "relation": "increases",
      "source": 8,
      "target": 65
    },
    {
      "key": "7cd1f4156d452a707387ea5632365f0252e474b7d90fe03d2534bbf82fb381938d7abb0e2738a721b4643026bb1bc2f5ade2962a35a5b6ecaaa3462403bc8e6a",
      "relation": "hasVariant",
      "source": 89,
      "target": 90
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "6425284d09baea5d97561e74b3b3064d796cf17f9a5934164bf86661d6c9931d46549750a6703b8de584ead62df24129fd04252085a6500eafb22624c5f61301",
      "line": 202,
      "relation": "increases",
      "source": 15,
      "target": 53
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "d39d261e296ad5f30ede2838ba3b29d30a4804dbeb4a3d4e119cdcffff8626e8e11c6503e97b71c9d0b524acb263bc970a238d861188fa6c6cea643f3d89b54b",
      "line": 204,
      "relation": "regulates",
      "source": 15,
      "target": 109
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "567bf28521bc76e6a2060bebc1ecde45986fdb390fa3154a5d18b2955c964db9e75c3fd3b557e6b838cb133898099d5353a724c2073850f7af3312b12ba6a89d",
      "line": 205,
      "relation": "regulates",
      "source": 15,
      "target": 110
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "f738547d18e109a58982d8c6f9e0cc688a15f9a84d781dae30cb1cdff1c88df28be67d14c21f5fb7efa249673831cac0ae6a4ace37edce9f0a6a3748261ab686",
      "line": 206,
      "relation": "regulates",
      "source": 15,
      "target": 98
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "1331e8c8cd657aa5f5c80932229edb24d90edb3cc0bf46eda1a1ed51eba94b10ab1fe6d8140b3ab934168ddfac2592ed9523cf1c938a32df8b1f5ed6eeacd67b",
      "line": 207,
      "relation": "regulates",
      "source": 15,
      "target": 92
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "b09b3373ff054a7a507bb8694f62aa43c6d189ce186215e3dcbba3b7ec4835222c190d4d4b61203c35d035169ccd08808dbcad51df951ba1e5458754717d9153",
      "line": 208,
      "relation": "regulates",
      "source": 15,
      "target": 77
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Salidroside ameliorated cognitive injury in an AD rat model by regulating the expressions of thioredoxin, thioredoxin interacting protein and NF-\u0002B pathway proteins such as NF-\u0002B p65, I\u0002B\u0005, IKK\u0005 and IKK\u0003[137].",
      "key": "0dc4267d9abce77e5ef4313e3683d55e4852609c04fe3f03e2112f53c8b81a885d94279db2454f700a2121ee9f013af4a4669794438c2d6a4fb8c7f41783436d",
      "line": 209,
      "relation": "regulates",
      "source": 15,
      "target": 82
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of A\u0003aggregation in A\u0003 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "e4fe15ae9570cb398c8ef0abcbcd34f923a0b3e39b05b9c825622cbe9642f3a3fcc9536befc2df3bd30710b5f40361b1360971fe872778cff19557624c2a4009",
      "line": 216,
      "relation": "increases",
      "source": 33,
      "target": 55
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of A\u0003aggregation in A\u0003 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "a21c5530e9b1ec110059c07b42c452720292d582c57261a20ee6764f5f3974789de32ea09e962095571c126d5f3617e97a544283fb608f0544b1556741ebda26",
      "line": 217,
      "relation": "decreases",
      "source": 33,
      "target": 26
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of A\u0003aggregation in A\u0003 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "72873ed47d67be7593e723fff218dd8383ff49318b58a274576c6e8b8bc5f7a543307919a8034a8fef9fede0430b62edf63f4e9cee03588b43b93f9642fb5e6e",
      "line": 218,
      "relation": "decreases",
      "source": 33,
      "target": 113
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Beneﬁcial effects of 4-O-methylhonokinol on memory were observed by the reduction of A\u0003aggregation in A\u0003 1-42-injected mice and memory-impaired mice with its anti-oxidative and anti-inﬂammatory qualities [141–143].",
      "key": "c9f5d843ca65fd56a188b8e02354c33f27981f6a6a170b801b44280cf22faf668de2932ad07cf53c997fd45c8feaac66828f2eb5cccc9a832d524e908f1acc89",
      "line": 219,
      "relation": "decreases",
      "source": 33,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "LPS-stimulated memory impairments were improved by 4-O-methylhonokinol through the inhibition of A\u0003 1-42 expression. ",
      "key": "9095072b1b7c64bc252b7bdd3faaabfc6a6dca2b7a368d22561b2d8e833a828bd51889798cc01be62cbc2cad0530ad389b87e1dc78da5870b6c12e5fee376bd3",
      "line": 224,
      "relation": "decreases",
      "source": 33,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inactivated\u0003– and \u0004-secretases and astrocytes through the inter-ference of NF-\u0002B activation [144",
      "key": "93242bb885747210f1b4c4416066526f32119781a2e2609342c0fa714930b70e54de1c3cb45c5f5622a771961a8816527792a00015c4638d0bd167ab44a4c68a",
      "line": 228,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 58
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inactivated\u0003– and \u0004-secretases and astrocytes through the inter-ference of NF-\u0002B activation [144",
      "key": "1be1722466a6bb11fdf1e965260e3c72d9ef76176544b147898da438e07a7cefff74acea64242c8d011adc388ebaee2fcb6cfd175cc3a7d9215c2249787b493f",
      "line": 229,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 76
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inactivated\u0003– and \u0004-secretases and astrocytes through the inter-ference of NF-\u0002B activation [144",
      "key": "78b9bcd50eb3d4203753ebf6ea6f363364968295379054097e153a58c609afefc54788b2c5119033d88e3c9a714f094ff1acc9dd1a3abe6761c3d016e1403b83",
      "line": 230,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 33,
      "target": 71
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, the level of A\u0003 1-42 was lowered by L-theanine and caused A\u0003 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "408203a876f0fcf0aba28841a6e8691e69d2d56fe6d2ea43fa7a1d2157cda388cadfcf8ea1f66532518c0c7e5f04cdd2cd859f319698487e4e10a5014a8347a0",
      "line": 593,
      "relation": "increases",
      "source": 5,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It improved ICV A\u0003 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-\u0002B signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "a18c0ccc0ae015f08ea5a4a6e19a79d31acffcd31d68e99e91a1c5c8480fb2bf2f040d3bde38c5049e5517291354f71f249dc2f9ff17928c6db5bfd000af39f6",
      "line": 235,
      "relation": "increases",
      "source": 21,
      "target": 114
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It improved ICV A\u0003 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-\u0002B signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "d73da8eff11732054518ca77006b19c2901f2e7ed051f95a11b78ff2bb57901023b18e9e294fb59d40b0d62fa24798acafc0ac3894791abb2dd125e0d2943596",
      "line": 236,
      "relation": "increases",
      "source": 21,
      "target": 55
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It improved ICV A\u0003 1-42-activated spatial learning, and memory deﬁciencies were ameliorated via the interference of NF-\u0002B signaling and the inhibition of inﬂammatory cytokines [155].",
      "key": "edcd9efe9a815d7a79502d742d7d8cac3d11ae24df0b8952b38c6f7fd72e62fb7c82172f3a4b21b7771ab493d614a35a327f2b6e476bc14a6a88160ec1a590d2",
      "line": 237,
      "relation": "decreases",
      "source": 21,
      "target": 46
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated A\u0003 25-35-stimulated TLR4 and NF-\u0002B expres-sion, DNA binding and NF-\u0002B activities[159].",
      "key": "5f185a9f8515a44cf0c8f68fdf8e57ca369f28e046b1d400f232fa3765e46654190efc3a2855d497028bcced77c2471e4180fea182ed75647df8dc99c737ef59",
      "line": 242,
      "relation": "decreases",
      "source": 20,
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated A\u0003 25-35-stimulated TLR4 and NF-\u0002B expres-sion, DNA binding and NF-\u0002B activities[159].",
      "key": "d6d53703891b3d8d4b2086f4c2b8dd7c054eb611b25d408ee827cea7955baa886b01bf49e3fc79abb870d5713a479962b09bb59cdb0bb31d727361ab30bfa368",
      "line": 243,
      "relation": "decreases",
      "source": 20,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated A\u0003 25-35-stimulated TLR4 and NF-\u0002B expres-sion, DNA binding and NF-\u0002B activities[159].",
      "key": "5e18b3020804946514683e72073a37e7d1e2aa19e18f455809a07533a72317016c81279499cfcc1c9b546920276d73fb5dc00b62d0e8c6dd5586b04031316368",
      "line": 245,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 20,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Pretreatment with genistein signiﬁcantly alleviated A\u0003 25-35-stimulated TLR4 and NF-\u0002B expres-sion, DNA binding and NF-\u0002B activities[159].",
      "key": "87c1e3664035d65e0c31a4c3b7b69e71941ddab210a42a6b583c05f84195e81cfc177dd69f3cef1bd1d2e9b89ff651bdc8b27d299c15c1b05aa10cfb47243a5c",
      "line": 244,
      "relation": "decreases",
      "source": 20,
      "target": 57
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "ICV infusion of impairments by A\u0003 1-42 was considerably reduced with the treatment of obovatol [161].",
      "key": "b6e38bb9434bbd747e582ac4df11a47dd38eae797bfa215a7051b31223390df2cbbb9951a9a240092bb4cbafeb9d3d0f46e725abf4d6a64dd82b85a57320dfce",
      "line": 249,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 43,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "5544f30e7ca1eba277fa7450697fa4cadd330adebd93359ddd882be1bb1085632b03783804ccebc02f4315cecd599abb208b879f87c9c2693ef4defcc92ff95b",
      "line": 255,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 70
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "2cf1dba90a8cdd0fc82bf846fd0f22d7d404f03838aa4738d23d781f0f497f659bbe90b5f99dc9b125ce431bdaa2463de877c4bb62395d06d177a14d67b8f6f5",
      "line": 256,
      "relation": "decreases",
      "source": 7,
      "target": 99
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It revealed potent anti-histone acetyltransferase (HAT) activity and inhibited RelA acetylation via direct inhibition of HAT enzymes and consequently down-regulation ofdiverse inﬂammatory signaling pathways [163].",
      "key": "e6eff8b8037035b623261bcc5c733b32d81e34e825e1b8af63c3e9b4e7ee2fec7ce34bd965de40adf31fd6b7c35a414c9c5e18aabc8e7c2846b08439b315a65a",
      "line": 257,
      "relation": "decreases",
      "source": 7,
      "target": 116
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003-activated NF-\u0002B activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced A\u0003-activated neu-rotoxicity [164].",
      "key": "0312220aaa3f14ad0a0195cc3aaf0e01bd0f87ab7a66f4204a02a3f80bd0352bceac41c103a07191745f4ecf656d0cec83b1a44da3e1cfa974113640299ac223",
      "line": 264,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003-activated NF-\u0002B activity and the expression of cytokines were attenuated with gallic acid in microglial cells y decreased acetylation of RelA, which subsequently reduced A\u0003-activated neu-rotoxicity [164].",
      "key": "19f757a185c7e7e02bfe91d8910d12827d26b20f592d62f0c810a78c9f34a05aee8a63e151c0312acc7294a6cefa23afd2674acfe86fac7566667f30ac547790",
      "line": 265,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 7,
      "target": 6
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibits AChE competitively and reversibly, causing elevated cerebral concen-trations of ACh, and thus, enhancing cholinergic activity. ",
      "key": "d9891843cb3eab121b64150eac37c817b20ccb13f60c57d82ab7c258ee231074daffb3169da9ce64e38b38bfb0ced553f32c4a89a87853b4b3ab8e635fee2857",
      "line": 271,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 19,
      "target": 75
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibits AChE competitively and reversibly, causing elevated cerebral concen-trations of ACh, and thus, enhancing cholinergic activity. ",
      "key": "529d06fee4d0c06ed9e49c206f1b75422f59d1cec01aa1db599e89ae9ba0ce9eb6d379999a7622b515d8ffac926e588d5658309267c577ccb1fe4bbf90605054",
      "line": 273,
      "relation": "increases",
      "source": 19,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, galantamine allosterically interacted with nicotinic ACh receptors to increase the agonistic activity of these receptors and ampliﬁed the ACh reaction through stimulating ACh release [165–167].",
      "key": "2e1b5ac4d09ffc1e40abe50f492f9afe0ee07a3788fdb51f30db77b894dda30e440fd6e160b874a50971068ea81c817aa694ea4857d253378ec95cea4af2e35c",
      "line": 281,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 19,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The protective effects of galantamine in brain microvascular endothelial cells were mediated via protective gene, heme oxygenase-1 induction through NF-\u0002B activation [168]",
      "key": "9be8ba237e3e9f0f531503607e6d42c17858fcdc2a80c00f8894847e570829d5bf932cf2f35161b31de8719d27cee4207a8134d574cc958f9da9f98d45ffeb3f",
      "line": 286,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 19,
      "target": 80
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The protective effects of galantamine in brain microvascular endothelial cells were mediated via protective gene, heme oxygenase-1 induction through NF-\u0002B activation [168]",
      "key": "543b6e9d35dccdbb44a3dfb421c0c3697648e7a6c5bf8b5ccd2eaeda1e0ad5faedea48bd06a63c37c9ff4da0fec387df2c29588a193508a8dff10d484f0460c1",
      "line": 287,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 19,
      "target": 71
    },
    {
      "key": "e145f7d0700369dc038479444e833c72cd75e42c695bcfe013c656b9dab15ec83a830377fce452b5b0903a79063f8e5240010e3476cd2b10b41a56c758ade3aa",
      "relation": "hasComponent",
      "source": 56,
      "target": 19
    },
    {
      "key": "b5e397ea008eb9493ab2e6ff724d052ae24d01d03df37a2e5315a5d67694f190566e016b9cc819f5df52dcf1dc3b313769e1a4142efc2078f9c4f651904cc1d0",
      "relation": "hasComponent",
      "source": 56,
      "target": 63
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, galantamine allosterically interacted with nicotinic ACh receptors to increase the agonistic activity of these receptors and ampliﬁed the ACh reaction through stimulating ACh release [165–167].",
      "key": "55aa4a3634729b08d333dffb94d99eb8ed268aec15a2b85da7947ea83ea8202881097aa78e12645ffbc89a14c5eb2d188e6206ca2f5870628f04ceba2d7bc950",
      "line": 280,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 56,
      "target": 63
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "edabe9f55c4fdf264db008c63dde99c45a619d0da491b57af21fcaa16e03207f22374030f93ab41338c3184049f8853ea1632f85b3ef86c4ddd4d22d3790d7da",
      "line": 294,
      "relation": "decreases",
      "source": 32,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "fdcc0f1fa223de579fbb8d21fcd7ff6ee0e48d0979ec7eb0cc8cd7ca01d5f1090d93db9051e098656a7fec3c43650e5a89f2ce5623f86c03e09f4f2f7ce99c46",
      "line": 295,
      "relation": "decreases",
      "source": 32,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "7ce6f43c952594cf76f0478f951a0d5fcd0cb2910376447aeb71fb2cdcc4bd9d8c7885e8ec84e4c12dcab9ff9e574ac745f993aaee3811611385bec6109fbc2e",
      "line": 296,
      "relation": "decreases",
      "source": 32,
      "target": 84
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "eee3115ebff5e39c2fffe6fc1f830cd4dee51da1250c2ba5376602944b317607d7bb81d0282852d21f035a9ea7541aa3104d831ea717b33ef09c6e9b7432848d",
      "line": 297,
      "relation": "decreases",
      "source": 32,
      "target": 96
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "514d50f859c2acd3a789f97763c1d400a627221d4109182b038065271860c45e4c20d2a5bf5b4a852350f705c54172ae308997d6b2a01aac4a969b89e779befc",
      "line": 298,
      "relation": "decreases",
      "source": 32,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "c0e9d91add6bfc593280c58ffae37470d41b566cb1f825929cbe58568827ebf06e06da0076f012d233cea95c00aa15acb2937978d3cbfe61ba5fb71a5b08cc7d",
      "line": 299,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 71
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "58e99abcbe7efdb7e02cc33b111ce32144cf78db9ebf3a89c8b6aafe9ff33dffc82648f5c5001b3d339f015538fa78353571fe7248055c2bd9990fe2f52491ac",
      "line": 300,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 32,
      "target": 89
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Glaucocalyxin B, found in Rabdosia japonica, considerably atten-uated the expression of NO, TNF-\u0005, IL-1, COX-2 and iNOS in LPS-induced microglia cells [169–172]. Moreover, the activation of NF-\u0002B, p38 MAPK and ROS generation was interrupted by glauco- calyxin B in LPS-induced microglia cells [172].",
      "key": "4dd1d5eab508868117a4aaed2ae2d856a6f52b4dc32e858dd1ceea3186a3363d2e9e2c2bb98ba38303c48cc6bf004fe21e512899e30ba01211742be36e355a26",
      "line": 301,
      "relation": "decreases",
      "source": 32,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tetrandrine inhibited the activity of NF-\u0002B and down-regulated the expression of pro-inﬂammatory cytokines [178–180].",
      "key": "d28540d67b0ee67a24326a881e9e1160c31528adaec96bc689d4c547ec2c53578ff1cf1fc912170b21f67c3e1b402f3eb7ac2bdb40524ad74b9c859072773bc4",
      "line": 306,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 44,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by A\u0003 1-42 and was associated with the inter-ference of NF-\u0002B activity and the inhibition of IL-1\u0003 and TNF-\u0005expression [183].",
      "key": "aab9556dc0be40ed8e62452d8c5b9eb6641a4fd86b2143af855ff3550e952b28df0121bcd273da1c836f6a614ec2a8be0adad10430b936157fb3e8937934f7b5",
      "line": 323,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 44,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tetrandrine inhibited the activity of NF-\u0002B and down-regulated the expression of pro-inﬂammatory cytokines [178–180].",
      "key": "fbdf9d5089ee83955c90a212405c3d1852ef79bc0f46b2120bf7e538b7323f008e12557bc77f38fec4cd5ad86571479b08d7763c2ff79e326518ba485b133251",
      "line": 307,
      "relation": "decreases",
      "source": 44,
      "target": 28
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-\u0002B inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and \u0003 activiies [181,182]. ",
      "key": "fa4bd3affda54cf3b4f17c39845e18b9bd6add0def9a56f6fd7b26220605da486f348375ac93d664535aeb796c7f816a52f30410af887b3b962547e576f2c69f",
      "line": 312,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "decreases",
      "source": 44,
      "target": 92
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-\u0002B inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and \u0003 activiies [181,182]. ",
      "key": "6b1a3ca9d82132d9220f325e2eede8f2cca4b6a8bdac17c2aa228efffb68b007c3e3ef424a36fa27f383ebfa5d479c35b97af8767540462f35b705d9cbcba5e2",
      "line": 314,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 44,
      "target": 98
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-\u0002B inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and \u0003 activiies [181,182]. ",
      "key": "06ad60ac940d9d33bc5f38d1643ed23fc001f29c039b0caa983677eaeb6a27ae0e3b0ca816c835b796858dc118c7d9ac23fb70f0014c4d743635bdce90a9a221",
      "line": 315,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 44,
      "target": 77
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the degradation of IkBa, a cytoplasmic NF-\u0002B inhibitor, and p65translocation to the nucleus by disabling IkBa alpha kinase beta and \u0003 activiies [181,182]. ",
      "key": "49f2d7f83de721fd8490c82e3919c6bd28b2d06978b8fd2dc4869a59ffd34bf2cda6596aa118e7297f1f850e5b0514f088eb70c5c3583dda9cc7137e3b29b926",
      "line": 316,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 44,
      "target": 82
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by A\u0003 1-42 and was associated with the inter-ference of NF-\u0002B activity and the inhibition of IL-1\u0003 and TNF-\u0005expression [183].",
      "key": "3f853d84a264b411668d636e6327116e7e0fa0571ee34937b19e9305b41b42bea49d076152eb3864d09c223359de22c36a9a68719f5e899c6d71e1732ae8e363",
      "line": 321,
      "relation": "increases",
      "source": 44,
      "target": 114
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by A\u0003 1-42 and was associated with the inter-ference of NF-\u0002B activity and the inhibition of IL-1\u0003 and TNF-\u0005expression [183].",
      "key": "7026be622d6d57f9062e5800272fce3c21c3213d361d440dc7df9071c07e22e7a3265dd361f341929ba353ce957391a75181f84a5edee8dd56192e07eac35df4",
      "line": 322,
      "relation": "increases",
      "source": 44,
      "target": 55
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by A\u0003 1-42 and was associated with the inter-ference of NF-\u0002B activity and the inhibition of IL-1\u0003 and TNF-\u0005expression [183].",
      "key": "90da70bf703ba4b16dadb82c52daf6e78cfe4eb6ff4a7f4bf02e18b427bbf5895b4090252456ae34abf26c97edf55b1c274cc04286b828bbd3bfe27127ede9e3",
      "line": 324,
      "relation": "decreases",
      "source": 44,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It ameliorated spatial learning and memory disorder, which was caused by A\u0003 1-42 and was associated with the inter-ference of NF-\u0002B activity and the inhibition of IL-1\u0003 and TNF-\u0005expression [183].",
      "key": "a6a7f9bc0d5878b98ebb7151f0c533ffdfe745be5b5021d69fb218877a56bdf7b259506e528f52c388c19d09f05802f64fed73fb6ab6619bfe862512d956e206",
      "line": 325,
      "relation": "decreases",
      "source": 44,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Berberine suppressed inﬂammatory events occurring in several inﬂammation-related diseases [186,187].",
      "key": "0c9a2e26e44faa5e2262e9f138e2e7ab096f3c43a20250ff0ac4b90e90082f3a22656d551ea03e585493c69da6fbde264247cf0bd1e6db4488a2aa145301106c",
      "line": 329,
      "relation": "decreases",
      "source": 17,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, berberine decreased the phosphorylation and expression of p65 [188].",
      "key": "e030c4a4f273968c74477dcb6eb0a1981cb428e133db271a5e38fbf43e30e16a2bc39e84f2492917e971f1d7bbf119e254c90ee8dbad6e11acd290b156931360",
      "line": 333,
      "relation": "decreases",
      "source": 17,
      "target": 100
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, berberine decreased the phosphorylation and expression of p65 [188].",
      "key": "0adb8f9280dc0c6db8f7381cce43d649e0e7560030f7fa19ec0362a03468f69ff29001bec66f242af927f174c21a274a8f00dd0fc79d4b2097669b59099eb187",
      "line": 334,
      "relation": "decreases",
      "source": 17,
      "target": 98
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Also, berberine inhibited the phosphorylation of I\u0002B\u0005.",
      "key": "8b4e207fdebfd55acea54addf57f73a2811b307bdf4374e5449160a4f034c2a006d458e3929f7a54583413b85a418f941c6360a912dbdced8ae03659f9061ec3",
      "line": 337,
      "relation": "decreases",
      "source": 17,
      "target": 93
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by A\u0003",
      "key": "ab8ff0383f3a3bb7887cd98b6607349b5a68215ae9602840bb5616cbe8696f5c9becef8700add5be70b9221277db1b749ebc9c7a88631f70e823250907bc5d67",
      "line": 341,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 89
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by A\u0003",
      "key": "e7e1e389321fbd23f001f996af4c858653dbec44e2aa8a5bfbce401b3086b5f217e0e9b165cd3bdc86e5ec78a5bf8df5beadfa7a502bddebdb1cad7c3e1d313c",
      "line": 342,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Berberine inhibited the p38,ERK and Akt signaling pathways, which were stimulated by A\u0003",
      "key": "5276518fe4458abdb3e98b4eb09f3aae170f719983ab72187d32b1e01e1da8cc82a7982fbdf3808100d6cd643fde5ee9840f2a68f17c5ddcc166d6ba853b87a1",
      "line": 343,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 17,
      "target": 62
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of NF-\u0002B in TNF-\u0005 induced HepG2 cells [193].",
      "key": "3aa1cfa095468ba2d2f7b7d1d85de21b89e8c105665d5ce249b6cb0a887e73fec6015829110f9580815836587a77c553420c81c03af20fcf963a0ad888e02886",
      "line": 347,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 23,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it attenuated cognitive disorders nd inﬂam-matory reactions in A\u0003 1-42-activated AD mice[194].",
      "key": "02e66d06470173d2b03f3ee4dc8c6046b8c9f67a2ff499e36801b64d4f773b17f3c11bfda7ab2caacec3ed365daaebc171651c65f965a1f95c9863eb10e6bcd8",
      "line": 353,
      "relation": "increases",
      "source": 23,
      "target": 53
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it attenuated cognitive disorders nd inﬂam-matory reactions in A\u0003 1-42-activated AD mice[194].",
      "key": "4289227e2b68b2e5cdc05bc5420425c3c2a7b1891513dfb6af151f9852d9ef67067c7926b5350b2254365ffa6fb83e7b8a9810c09aa143403f76ccd4db8904f0",
      "line": 354,
      "relation": "decreases",
      "source": 23,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Anatabine lowered NF-\u0002B activation by inhibiting A\u0003 production in vitro [195].",
      "key": "93459c0dca23fedac525e8992825e6db31ad7fc4aaf6819f21a23dbddbddc2dbd7d3191068e75ad643e72b0253b6de5da21a47a12f6aa7e0a5045d7cc08dc25e",
      "line": 359,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 13,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Anatabine lowered NF-\u0002B activation by inhibiting A\u0003 production in vitro [195].",
      "key": "4ce6015f2f11598b1c25a218def02646f8f31bf1217a56a885221ee4bd70aa2bb210daec738b7983d93a5609557e015583e1ad44cf57780414df412fccaf87b2",
      "line": 360,
      "relation": "decreases",
      "source": 13,
      "target": 6
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It con-siderably lowered the expression of A\u0003 1-40 and A\u0003 1-42 in an AD transgenic mouse [195].",
      "key": "fbbb6aaaf592eff32fd2cc8b84d30fcdb04cbc34d15b86d6a69b2ddf232fd9daafe9e3af22b203361bdea6e07bee3634319fc52c6c81320975aa52b145a90ed6",
      "line": 365,
      "relation": "decreases",
      "source": 13,
      "target": 4
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It con-siderably lowered the expression of A\u0003 1-40 and A\u0003 1-42 in an AD transgenic mouse [195].",
      "key": "6a877d253d3adb27d5cf3094dfc85cb8e2324bda7f68e25f2b868c5bb3af8a8e5a002f14b714257325ad788bfa69200a7176701e787ae3c0fd7d06eb1d8dae77",
      "line": 366,
      "relation": "decreases",
      "source": 13,
      "target": 5
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-\u0002B inﬂamma-tory pathway in A\u0003 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "560d7a658203cb181158d20a406cfe264510da5a94d8e84a81b1006dd39343eba8de8444e77d6ae64c65f669b2ec11287708ca864c44c297101fda951088fbf3",
      "line": 373,
      "relation": "decreases",
      "source": 12,
      "target": 72
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-\u0002B inﬂamma-tory pathway in A\u0003 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "ff805c67df8495fab5b1886e1b0cf3cf319b6f7af14006d01dbb413fe4ddfd1b757a749caf9a8681a065dff505c5d2a18bf60dc0432cbcaafee610d1d485d866",
      "line": 374,
      "relation": "decreases",
      "source": 12,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The phosphorylation of the NF-\u0002B inﬂamma-tory pathway in A\u0003 25-35-stimulated microglial cells was inhibited by vitamin D2 via reducing ROS and inﬂammatory cytokines [207]",
      "key": "986a42cdfa75d533432058a481089ad733f60d8a95960f54bd858fe5cc7574b9a9f9a4607d0bf825eaa663fa33d3874739d17379e439994bfe8d5f7e296c0869",
      "line": 375,
      "relation": "decreases",
      "source": 12,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It has antiox-idant effects via the interference of reactive components and ROS by redox cycling of quinine, and subsequently generating hydroquinone [209].",
      "key": "150e510a163c47dbbd9623e2e5a0b0e0b9f61bae4ec23463f3427a917e61573913c7c6932bb619f57f28308574f1ebc5724e53ab81c550dde5cc666733da928f",
      "line": 381,
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Reduction of A\u0003 expression and cytotoxic-ity stimulated by A\u0003 in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with \u0005-tocopherol [210].",
      "key": "ab0e3706b6059051840ef407a508428e2070681f56ea46433bba12c66373b800e247b0e1a4ab4cf6f3fb484a1c23e80f387a4c2319253c7b1f05842897ae9d7e",
      "line": 387,
      "relation": "decreases",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Oxidative stress and A\u0003 expression were suppressed with \u0005-tocopherol in mouse model.",
      "key": "b4fa2643ab935a1c955753749f13b76073539e7f35965f746488f61846fffb628e275318e3e6e9f00d07661d10d9cecbc0204ad297d104ebb5f85bc8636a1b29",
      "line": 402,
      "relation": "decreases",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Reduction of A\u0003 expression and cytotoxic-ity stimulated by A\u0003 in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with \u0005-tocopherol [210].",
      "key": "9bb07e4a2412233f76070afc998e856a1cd550f18c0901198b868b3de9e58a5c33d0d7eaf4dec237c7af0fa65e75fd50354131b9be40123e21e60437f55b30c5",
      "line": 388,
      "relation": "decreases",
      "source": 3,
      "target": 28
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Reduction of A\u0003 expression and cytotoxic-ity stimulated by A\u0003 in neuroblastoma cells and the inhibition of inﬂammatory cytokines, ROS and NO in microglial cells were detected upon treatment with \u0005-tocopherol [210].",
      "key": "538f362251a8fe59524ec1208400ddbe9e1c910e477116636e994d950b5c238df2968d02abe4ea9e99b53098b3491591f0e714199b9c5a29bb0db8eb21aaff9f",
      "line": 389,
      "relation": "decreases",
      "source": 3,
      "target": 9
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Memory deﬁ-ciencies were improved by \u0005-tocopherol in transgenic mice.",
      "key": "18d235ac01f25bbf06975a015788cf845254167a88ef1b4a84f92ebbb99bf3b41fd2d7c474bd3ca2e436b6b3c29aa91077d82dc1b079de7cdfbfb429deb48997",
      "line": 395,
      "relation": "increases",
      "source": 3,
      "target": 55
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Oxidative stress and A\u0003 expression were suppressed with \u0005-tocopherol in mouse model.",
      "key": "fd7135ec4cfba14d382d4488ff7128931a880adf7d1ad8cc10aa1c8ba87c30f8ae134db3be617c4124a9dce5ced11e7a3c857c79279cfe2982f8b5ee48aef21e",
      "line": 401,
      "relation": "decreases",
      "source": 3,
      "target": 113
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-\u0002B, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1\u0003, and the reduction of microglial activation [37]",
      "key": "f90d21ee852831210a004c6a64f9d4cd48e2e64a75e979bc02d752126def3002f7857b244936d66c9f93b28903e3025d95e0caec2256ed5478f3232cad2a3e02",
      "line": 410,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-\u0002B, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1\u0003, and the reduction of microglial activation [37]",
      "key": "06c93dd601e2d90652e59227bf60def3500634a34c72951d108f95b38a8d72651e4520a8590a95f452c247fb7c25172f7740658d4486d8e995c119a4a67e6286",
      "line": 411,
      "relation": "decreases",
      "source": 3,
      "target": 94
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-\u0002B, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1\u0003, and the reduction of microglial activation [37]",
      "key": "a7c5b8545edaba43dba75c44886eae47ae3a29fc0209d04143f4e72689999cd9472769bf2b17ea0568d3c8bab3cba354163faeed904fb6203619f88439d3ad96",
      "line": 412,
      "relation": "decreases",
      "source": 3,
      "target": 87
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-\u0002B, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1\u0003, and the reduction of microglial activation [37]",
      "key": "826d954b075e407a5d8b767e4bf72a000ece1a63652cef361a2fd3df7047cc1687fa890090230e784fc8e34ad95a3c33df55ed4be4d0088cbe0a11d5f80e2621",
      "line": 413,
      "relation": "decreases",
      "source": 3,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it disrupted the activity of NF-\u0002B, and thus, caused the suppression of NO synthase and inﬂammatory regulators such as IL-6 and IL-1\u0003, and the reduction of microglial activation [37]",
      "key": "ea2977b92db2d0bf676e5d36aed9ee50e0a47d3d826935b3727df9c4f5ef1f5e90f5a7f64ae9e0d946586f9f61b688f5a3082d56965d00c0c3d15b2e12cc781b",
      "line": 414,
      "relation": "decreases",
      "source": 3,
      "target": 51
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-\u0005 [216–219] and mod-ulating NF-\u0002B signaling [220,221].",
      "key": "108d42f23a1ace015af3bd2da6cd762b0b1b2c848dd7e5fe36f47577b53916142a43febf5a59767d8ea87b85e7de24b0e98af1692d20aa7e75c417537cc164df",
      "line": 419,
      "relation": "decreases",
      "source": 41,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-\u0005 [216–219] and mod-ulating NF-\u0002B signaling [220,221].",
      "key": "78e587690178345b6edd93ee9f56a4e79b0d054a7c0c89e56157b3bd7cfc315ce4c75bbcc77229c535fd5ea187b66f11b9dd273a0239b85b7db3fdea6992d66b",
      "line": 420,
      "relation": "decreases",
      "source": 41,
      "target": 87
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-\u0005 [216–219] and mod-ulating NF-\u0002B signaling [220,221].",
      "key": "92dc73badde0b1d1ad92a99a7d2b7a93a308657a1a2f6d709ad024d3d30ca69252ccb028aea49aef5ad3cd98092e762ace890b360b739ed168d740b95fd778ec",
      "line": 421,
      "relation": "decreases",
      "source": 41,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-\u0005 [216–219] and mod-ulating NF-\u0002B signaling [220,221].",
      "key": "d96e59eb2b229b21b55e2550e39c4672d2a5f67ada4e5244c19db7c9158af9470e75c8e037475d45f029ec9aecef4bf5f9596438e0f30f8aa7dd5f380fac88a4",
      "line": 422,
      "relation": "decreases",
      "source": 41,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Retinoic acid showed anti-inﬂammatory qualities via suppressing the expression of the inﬂammatory mediators IL-6, IL-12 and TNF-\u0005 [216–219] and mod-ulating NF-\u0002B signaling [220,221].",
      "key": "07f7124fef6f77da5903498456138264802641611f9c65b426f47cc0b21c0dae6f6ead8ebc8b9621e16c93aa40ae42d0be54c3ab4e33cb983fe54268c78d8fb0",
      "line": 423,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 41,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It reduced BACE1 expression and repressed LPS-activated nuclear translocation of NF-\u0002B and its binding to the BACE1 promoter [222].",
      "key": "970fabd9d0aa317ee0e24f55afab7c63189c02bdd22f44d1a74c13061971094d9a185d261c59b4427909a85b9cd0e60ce6e3427d85c4a58ddb04b783b54612e2",
      "line": 429,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Cytosol",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Cell Nucleus",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 41,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It reduced BACE1 expression and repressed LPS-activated nuclear translocation of NF-\u0002B and its binding to the BACE1 promoter [222].",
      "key": "39b0123696619420c7abd8105512f1bc66601b06d79f45c680b2a497017eb2817be856e45073f6c489ed63a4a6aa045b4524860efacec103c31b0dce0a1a535e",
      "line": 428,
      "relation": "decreases",
      "source": 41,
      "target": 76
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003 levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "e2006f3b2c03980317e95a87839c88f720b535b457fa81a1f53dff384f56fbedfb2701d4e38a93d37fafeb39698c5301dde9753da9a7ab0ffa665ba8d7d06830",
      "line": 434,
      "relation": "decreases",
      "source": 36,
      "target": 6
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003 levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "11f95eac509bddc5afcbbcb68671cba26fe31df65c1a3c3e895963ae13abf48881fc09552e4a366d6a84f5766e1f122840dd8f77deab96ccf49a620c1c04a813",
      "line": 435,
      "relation": "decreases",
      "source": 38,
      "target": 6
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003 levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "16aed66ba0b9e150e44bff6c1b14c81da62833ed841defa0416b71d7c54e25cbd3b208669fd75610d52e8ebccf2a83e89cf1bd43699a675ef76e78116c771363",
      "line": 436,
      "relation": "decreases",
      "source": 45,
      "target": 6
    },
    {
      "annotations": {
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "A\u0003 levels in the brain of mice were consider-ably reduced with treatment of ginsenoside Re\\Rg3\\Rg1 (25 mg/kg)[224].",
      "key": "e279a7214047bef6c811480ad28b65f3a27e46ce26799b5b42efd8f15e2c324e0c13940990e4bb2b2f95c640b5505732cc792258d62f6ef4eedf5e912315b323",
      "line": 437,
      "relation": "decreases",
      "source": 39,
      "target": 6
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "2e6879342aa7ab443719f047efcee526b4916885845d651a51fb846956e667f9889a0e3a51ed203a434f9cc50b2961177084bf8cbfb93c4c9c4d049d53230213",
      "line": 460,
      "relation": "decreases",
      "source": 39,
      "target": 118
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "d39b9848086a31690654d02697ae7fcfbe0551ac586f0c9f188e595eabfbbdef745a0f9010f411433c4a1020e4d12c23f2c656f984a5b8333ce0d34512dd6738",
      "line": 461,
      "relation": "decreases",
      "source": 39,
      "target": 105
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "926f0fc29d3f245b819788766dd6f5a2f0169b6b43a98312c0e1c2a9979c407b25df816ca2ef97e649dcf201e9fbada37124b4da7c724faa229c0e968e6b50f0",
      "line": 462,
      "relation": "decreases",
      "source": 39,
      "target": 119
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "74973bbe04c3b8962d0e595a8b9d4fe5d1b5db7c6a8c7cb075cc5ebd40a5305baaf559a4ceb24171e5ff1f1341a65a6d2d74f4f6e72b47c4c389e841db2b8244",
      "line": 463,
      "relation": "decreases",
      "source": 39,
      "target": 106
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "32d93b256130136cff6be505099bbbe7771ab7575fc72e627f2c4135899a4cc235e5bc538efbfd328e478d59fa0dc73434c1db7495f970484dc5fe9b8183080c",
      "line": 464,
      "relation": "decreases",
      "source": 39,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "765a2c4a39116a4f854f400768521b1232e74180273734b7ce4f92b305c71cb257ddd5a05cbae1d357d10202256047fe1e08942f0c5d6a55e8a3db23e43a566a",
      "line": 465,
      "relation": "decreases",
      "source": 39,
      "target": 120
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "b4ecfc7ba4ebe0d3ab54bf5451b783a74dc4b21971239b768785e6752c3cd9eb24926e61d6acfcacaca429978674b247e0c73b9595f1a3627c57f06ce3437dcc",
      "line": 466,
      "relation": "decreases",
      "source": 39,
      "target": 108
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "5b400bd9d153319ea5502335cb14157954139e97e67012131a549f29860168d346ae14eda0cb1ec661cdc67409a4abefa64311b13d31f4b5a9e1de2e5ac49590",
      "line": 467,
      "relation": "decreases",
      "source": 39,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of the protein and mRNA of TLR3, TLR4, NF-\u0002B and TNF receptor associated factor 6 (TRAF-6) were substantially decreased by ginsenoside Rg1, and it also decreased the expression of TNF-\u0005 and IFN-\u0003 [227]",
      "key": "8ad379a2d96ac272300fa293d4e419c9f4f6fce6dc79c916a834d63cf8a4d2e35239e87f74ad670365bd06fa23a409f69de7d6c806b16f601f3290df4db8a049",
      "line": 468,
      "relation": "decreases",
      "source": 39,
      "target": 81
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with A\u0003 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-\u0002B [226].",
      "key": "9aaa13339b69ecc6be648d538c964c902f171b414698df4e8dc4ee16af224ecde362c2fe6f314dc789f5f3f7c8a06088dbab6359219fe9e38b975f9ed1988d7b",
      "line": 447,
      "relation": "decreases",
      "source": 35,
      "target": 52
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with A\u0003 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-\u0002B [226].",
      "key": "2906164bc9cae5a7f6c1c8def7e8b687c168397b3033a17005a197bfe7b69896843f6eafdaab967f83ffb487cc388707f580b8db15e5e0535a7acf6d250a1ef4",
      "line": 450,
      "relation": "increases",
      "source": 35,
      "target": 54
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with A\u0003 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-\u0002B [226].",
      "key": "e3e27c843a6dbb956a1c853ee2f7a812ee6634b4d38de91e635915c0d7d6debb678e53ce2c7f7adf9ad9036930cc5e6b7ff35b4fa54fff0e6b62fa8676742295",
      "line": 451,
      "relation": "increases",
      "source": 35,
      "target": 55
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Ginsenoside Rd showed neuro-protective effects with A\u0003 40 activated impairments in rat brains [225] and ameliorated learning and memory capability in APP transgenic mice, via reducing the activity of NF-\u0002B [226].",
      "key": "ad6b7032013511977f011ce4edd29034839f26f97541bb1251483366e84b014802cc77b979595761cac515f5b0a798461561cc4f98a2459a22b368eedfbacebf",
      "line": 452,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 35,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-\u0002Bp65 and consequently prevent AD in the brain [229–231].",
      "key": "5e6f3c9dcf7ae1d8ef0b4b3d996fe328af5a20e5dc7b0b32a90f73fee3111ed636af911f3440e6be41796e4ab1544116ad355d50d6dc6efbfb0d936960dad787",
      "line": 472,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 94
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-\u0002Bp65 and consequently prevent AD in the brain [229–231].",
      "key": "0fed392ee32fa49418f9943beb7d785f11fc2dc0fd801e9b8857b50a130d346a4f8671c0216d31394f4d8a89a66ee55436bd01bb7766df29c2ebb6a2dd09c57c",
      "line": 473,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 91
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-\u0002Bp65 and consequently prevent AD in the brain [229–231].",
      "key": "425d510fa57903bfd20b384e9ace4bb26a2392439e3106802f049b6267a6919d413799dc9d8798f44587dd3db97e567dc5803eb59bb199c993b0d78988a3e034",
      "line": 474,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 34,
      "target": 98
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Brain": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It inhibited the activation of iNOS, matrix metalloproteinase 2 (MMP2), and NF-\u0002Bp65 and consequently prevent AD in the brain [229–231].",
      "key": "0bb8906e6976b37ab83e660456af1031f3f9c87f9cff02ff7260ae17f116b16d08a05b736369204eb0e62096bd906b708206983374ab04510133838bf974f1b2",
      "line": 476,
      "relation": "decreases",
      "source": 34,
      "target": 112
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in A\u0003 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "10deb9f8e6c716552019f6cd83d5e66b49c2b5ec02bef010404ac937dc5caba15f63ead20ab7d04e07b19e87e1ad93a452ec17f504ed41083e2701c32bb37839",
      "line": 483,
      "relation": "decreases",
      "source": 34,
      "target": 48
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Atherosclerosis": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in A\u0003 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "3ba1a7832119fde36a7999548662e515f4409d9276a7fd066994d9f7c951a538441f8d8822c5281016be94508b055e793b630ffdbfd0f47c9967123e9a175ab5",
      "line": 485,
      "relation": "decreases",
      "source": 34,
      "target": 116
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Brain Ischemia": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, tanshinone IIA inhibited apoptosis in A\u0003 25-35-induced cells [232] and exerted anti-inﬂammatory activity in atherosclerosis and neuroprotective activity in cerebral ischemia/reperfusion impairment [233,234]",
      "key": "9c58f9ccb5d74e84ba1cccd4eced677be2f3ed2dd61b73c7fb784b30b33bd8c94578627b1a820940f748639eb393ca110e365ca44b4b4fde9c72a16d0d3ca56a",
      "line": 487,
      "relation": "decreases",
      "source": 34,
      "target": 52
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-\u0002B and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and I\u0002B in AD [235,236].",
      "key": "47a0f6039b3db9b9666b0419391b82a3c0d0d84cd266c3b5d302e8664a2e3f70f145040e2a32c454f53f4021d860872f8ad1be4bab6a77c6dfd727e828a163fa",
      "line": 494,
      "relation": "decreases",
      "source": 34,
      "target": 79
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-\u0002B and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and I\u0002B in AD [235,236].",
      "key": "b6b5787f331f9a58018a8cdd91ab73abc8b75277e6b68a585ef115d2620a80b8638d8a6dcfec8b27e9fe3ebf6d6f80d137ac8ffe5d2c64be6fe6fe4b713645c9",
      "line": 495,
      "relation": "decreases",
      "source": 34,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-\u0002B and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and I\u0002B in AD [235,236].",
      "key": "fd120ba5dcf31f961f8d1ee288a30e67717229a17b0322b97cf566a9901aa3414fc1ae4a1a56ad124ff095c7775f75416e60aa198633745c63eeeaa8aa52d8d6",
      "line": 496,
      "relation": "increases",
      "source": 34,
      "target": 97
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-\u0002B and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and I\u0002B in AD [235,236].",
      "key": "4ec50b9d96aea33ce9a7b6706cbfdd709168afedbf59f440343be743fba0709bfb1446ea056b8c2577f05ca7e9d6f6bde2ef06c18349d30e37b11d84cc9ecba5",
      "line": 497,
      "relation": "increases",
      "source": 34,
      "target": 27
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Tanshinone IIA reduced the glial ﬁbrillary acidic protein (GFAP) and NF-\u0002B and induced the expression of neuronal nuclear antigen (NeuN), Nissl bodies, and I\u0002B in AD [235,236].",
      "key": "6056942cfb5c2d94b097f56314b6cf68033be609362849abab37786d8456dd924b71f63214d45efd0bbef7b368b1790d319e0f4b68eacf4a1847d193f4531742",
      "line": 498,
      "relation": "increases",
      "source": 34,
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover,it reveals promising anti-inﬂammatory actions through suppress-ing the activation of NF-\u0002B [238–240]. ",
      "key": "0301113744c2ef3e440155d11a80ac54123aef8b12f10daf1387a304ab7d7d22bf0076d24c43736773df4f80d585caa3f380bb743764669ac7b90a66cd910172",
      "line": 503,
      "relation": "decreases",
      "source": 0,
      "target": 116
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover,it reveals promising anti-inﬂammatory actions through suppress-ing the activation of NF-\u0002B [238–240]. ",
      "key": "04a4028890f3470fdfe22d51201e51eb40faa89e63e719edc70c4dab37f9161676af07d11e94aa948a317636b4d1117a006d3e18a49158e8f1c878709d7437f1",
      "line": 504,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 0,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of A\u0003 was lowered by artemisinin through inhibition of the activity of NALP3 inﬂammasome in APPswe/PS1\u0002E9 transgenic mice [241].",
      "key": "68152e4c1180186c65d1da75519e7927ec4e5cd316c557076ed344a2b8a3dd6fab029cedb4504e6286f9aecb86af18795ecd5499ab0754cf9e12bcb5015e12ec",
      "line": 509,
      "relation": "decreases",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of A\u0003 was lowered by artemisinin through inhibition of the activity of NALP3 inﬂammasome in APPswe/PS1\u0002E9 transgenic mice [241].",
      "key": "d5c4873c4cc70c26573737fda8691ef3d3a7b9683e0b4c3568ca51d370bd26d9304083ce0d72a8475f56c0ce852369d9383dfe1d41990dee8823b04a7c175634",
      "line": 510,
      "relation": "decreases",
      "source": 0,
      "target": 47
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "679147bfb1e85b79fe487bac74ad1a241b0623280b51095a3512e4cde6d9d3a100274a92c6d59ae2e5785aa87f0fa8cc05c2bd1622c35622bac764c53bc0c5a7",
      "line": 518,
      "relation": "decreases",
      "source": 37,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "6d25f4733c08f0734e24ef428dcd68f0a31357d2dcb22fde8ac0adeef7bad1ee7e6639d3a54b52387fe2ac0423d0da222b302ffaa28061a6af3e25cdbd42bab6",
      "line": 519,
      "relation": "decreases",
      "source": 37,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "735050554e5e4d0f436e9d313556f28b88954e411d0432ec9f14817fb8284bc30886c5c0cfc7083dd421f8ac5c04dfd457029b26d4c14169e1e0299e50547ea9",
      "line": 520,
      "relation": "decreases",
      "source": 37,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "05bdb098ba4b329679017ec2791884b0ac812ac15b2913a65035bdb59fce370191c428095007cc4ba468a901de8875d467682531ca99abf2e86d9e01cd988219",
      "line": 521,
      "relation": "decreases",
      "source": 37,
      "target": 94
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "7ce1d6f69207c174f49dbadd2c2fc64988f3a44c23be0045594a9f4716317c3629b32fad4f1ce93ea38587c03f0ab88f42b900f03dd95bb716a7def4a2e8966e",
      "line": 522,
      "relation": "decreases",
      "source": 37,
      "target": 96
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": " LPS-activated expression of pro-inﬂammatory and neurotoxic factors like NO, TNF-\u0005, PGE2, NO synthase and COX2 production and LOX activity were inhibited by dihydroasparagusic acid in microglia cells [243].",
      "key": "f4846babf7826ddcfc7e07fbd6a568767f0d3fb193b665e7ba59c8551f79bee7633ac5990a886d9e2468d1b24f993a304c985f27db7683b98060b9b9fd5e4fe0",
      "line": 523,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 37,
      "target": 88
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-\u0002B signaling[243].",
      "key": "e2e4f88d911b683b4a9f21e00f92a11be49d3798d9fbbd4589f058a81a6149944628969a21e4debdecbcb43851a4fe8c9065cdc5a71d4db968b2833d267246f5",
      "line": 528,
      "relation": "decreases",
      "source": 37,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-\u0002B signaling[243].",
      "key": "c1cad4aec9e7f9b8d1778fc87bc33131092783e0b9ec47b7fb0ef96641cc535971844939a8aee5907773644546cfe827847f7a91f41ca36f64d6c1d38bc50f78",
      "line": 529,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 37,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-\u0002B signaling[243].",
      "key": "62d3d8bc4aef2db112504e780b771ee9e861e0ba099607c14b09d782df7377528d9a68e737d5061e0e4b342561d9b05358eca07fdddf273be851966d393571cb",
      "line": 530,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 37,
      "target": 89
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, it signiﬁcantly decreased the generation of ROS and affected LPS-induced activation of MAPK, including p38 and NF-\u0002B signaling[243].",
      "key": "b12a8282048148c82f075cabbc40fe6793612b6fda990613f387d24624157d4543a3f050e63f63dca6835bf3c2042a4e4045648cbeca460ffebf60ffc51e3851",
      "line": 531,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 37,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "e45b7160287895a0d10680217944bcd589c39001babc80ebec5dde2975bc89f3e9eac223b3c4c76ead9c39a7287b30a7af4c7c2f9c5be3327da1e46641c74b81",
      "line": 536,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "a65c7671457ecc797cae9ed6aff23a3f4278f9d50964a22aa82515cd1525a199bb4a1f78a57189b5ab1230a53f6ef524884d5b23519ae1a6aab33016eebb6522",
      "line": 537,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 67
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "0d8e3b21ed9c1f2728391200aa9816537d6b81914e3428bbe1caa6e27aba6057581b456c39cbe669a1882708817af84a26762d456c908ae44e336a8c40f18214",
      "line": 538,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 14,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "b022ac0b95087ad79c0b7158bdd191e3abef61907d23d4d0271969f29f78e12c90b65ace9d8a90a555afd3ea317c3bab7d163a279543a2735d3ffcafd76afa7c",
      "line": 539,
      "relation": "decreases",
      "source": 14,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "3536efe96b9ae673b95253c621ddc4cc8e24bcd4f2ee4406994ad97496cdd00d922aaee0623dd6c59a99efd0790205b61e41266f63e6ef7d72e4c437b046cb4c",
      "line": 540,
      "relation": "decreases",
      "source": 14,
      "target": 85
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Geniposide considerably suppressed RAGE-related signaling such as ERK and I\u0002B/NF-\u0002B, the expression of TNF-\u0005, IL-1\u0003 and cerebral A\u0003 accumulation in vivo[245]",
      "key": "486c608211c5de5921ad50332663eed9ef466e49fc32ff168c9158b949084962d8e88c05430220a016c460fd1efef6f53f2203722a976cd3cb693fd1f81abf5a",
      "line": 542,
      "relation": "decreases",
      "source": 14,
      "target": 6
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside alleviated the A\u0003 25-35-stimulated spatial memory deﬁciencies and oxidative stress in mouse models [246].",
      "key": "2671d929b2acc740987a7399755d7bd54f6f15f4a458255bc2e3247781e0e4da65881ec9744a588d1557c79b5c57e5780a76da8c00d0358e1d7cb357d62220b6",
      "line": 549,
      "relation": "increases",
      "source": 31,
      "target": 115
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside alleviated the A\u0003 25-35-stimulated spatial memory deﬁciencies and oxidative stress in mouse models [246].",
      "key": "8ae7c44ed7391e8a154daefdf3f7ccda3f2246a2a9160b2b3ddabf62c60018199b1630c2b2f6406f8fd1c0217c99a5bb5cc69174d201a0ba269d5fff6dad4a7b",
      "line": 550,
      "relation": "decreases",
      "source": 31,
      "target": 113
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "aacf47d2c08f92cb006979a64a4b9249ef06d779864a7b12aaddb3154645121bec1bba5c950db71f9d15b4a1e9bc3e344cbe8a29422a59bb4d3dd6fdb61e28a6",
      "line": 558,
      "relation": "decreases",
      "source": 31,
      "target": 94
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "0b3e031c5f9a5cd19018b81ac6bfd9207cebfe93bd464c8f99eab8dfc65b9073ba151c9f9115804c8be847e674583e557f06432ead83971afb7a7473e452df3a",
      "line": 559,
      "relation": "decreases",
      "source": 31,
      "target": 22
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It down-regulated iNOS expression and nitrotyrosin levels in the hip-pocampus and stimulated the mRNA expression level of IL-4 [247].",
      "key": "304303322b0359ac2a7e209d3de6880244593e8b544532185de2a8cca0205a1b18a70c8f739905fc004061aa4adfad57a8e04992141d49b7edb01a9123fcd057",
      "line": 560,
      "relation": "increases",
      "source": 31,
      "target": 117
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Furthermore, it inhibited pro-inﬂammatory cytokines, which were induced by A\u0003 25-35/IFN-\u0004 in microglia cells [248].",
      "key": "81f442d4cc765c8c44ec0679003184d038551e844e90e4f0fdc8fda4778a90a7c3733acd8686d6530f8c0ff1328481930164d5fb160651eedbf842d21e417ae1",
      "line": 566,
      "relation": "decreases",
      "source": 31,
      "target": 28
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of A\u0003 25-35/IFN-\u0004-stimulated NO, IL-1\u0003,and TNF-\u0005 in microglia, which implicated the down-regulation of the activities of MAPK and NF-\u0002B pathways [248]",
      "key": "f04160f67bf23680c7064dbb9d5a73e0fdc6e9f632d563d379945d58e2ff5afb66c691dd922d974cc24a9aa6e44435a049ae2fa82ea25d2ea7a0bc9fca276351",
      "line": 573,
      "relation": "decreases",
      "source": 31,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of A\u0003 25-35/IFN-\u0004-stimulated NO, IL-1\u0003,and TNF-\u0005 in microglia, which implicated the down-regulation of the activities of MAPK and NF-\u0002B pathways [248]",
      "key": "6aa68d96d9f6477a2019163ec3fa1ce689dde54bec39962ca4af1c731722f3b02f0773e3d01c598c7d79387df9349d1c5828e027f0784f5b557ae2744a1233cb",
      "line": 574,
      "relation": "decreases",
      "source": 31,
      "target": 85
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of A\u0003 25-35/IFN-\u0004-stimulated NO, IL-1\u0003,and TNF-\u0005 in microglia, which implicated the down-regulation of the activities of MAPK and NF-\u0002B pathways [248]",
      "key": "b920a0069a595ebb58dc0d0205264b23dcbc804d5ca854bb3ae65ac16f9f13d023ed69c96324cc13a004e98a031e68562036f9603994166c1d9dcba0f47280af",
      "line": 575,
      "relation": "decreases",
      "source": 31,
      "target": 107
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of A\u0003 25-35/IFN-\u0004-stimulated NO, IL-1\u0003,and TNF-\u0005 in microglia, which implicated the down-regulation of the activities of MAPK and NF-\u0002B pathways [248]",
      "key": "90eceff69a4e8c81196b325b2d0a43b646cb3979a05f51445004ace0d3b562be5343c0efb74362160f1bb10a46dd72ef2a76487919d71753a80dbddb850d5ffe",
      "line": 576,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 31,
      "target": 64
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Xanthoceraside decreased the expression of A\u0003 25-35/IFN-\u0004-stimulated NO, IL-1\u0003,and TNF-\u0005 in microglia, which implicated the down-regulation of the activities of MAPK and NF-\u0002B pathways [248]",
      "key": "fad361b74633f456beb8334448caa59fcf3e094faf5a59041957cf26b03addd3faf6a18ca8ec54415bccf5ad381278a19744b0cff2215190ca41f16ada967ba4",
      "line": 577,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 31,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It considerably decreased A\u0003 1-42-stimulated memory disorders in mice [128].",
      "key": "c31099d2a59eabeaf77b402e9a45b1fce6d1b5041c53f114e306a88e634a8d4bc7d4a646e3c1b35e63cf249df487bb4581b6bb966b383e233c7b5852a8077180",
      "line": 584,
      "relation": "increases",
      "source": 2,
      "target": 55
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, the level of A\u0003 1-42 was lowered by L-theanine and caused A\u0003 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "0c06d95921417df58ed7f6fdfb84d27429427a15cb468b0546dd37c295360b562772a2d94f51b8401c10dc387f271de886d6f23b92e621f9d5d75bcfb5b4127a",
      "line": 591,
      "relation": "decreases",
      "source": 2,
      "target": 5
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Cerebral Cortex": true,
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Moreover, the level of A\u0003 1-42 was lowered by L-theanine and caused A\u0003 1-42- activated neuronal cell death in the cortex and hip-pocampus of the brain [128].",
      "key": "952b9473f74566eef77c36c122eb9d2c406dacb4dddc354efc1c1b7f1da4c968c04b908a137a52636f87278da34d7290da677327d4d47f297544c7bf2643adef",
      "line": 594,
      "relation": "decreases",
      "source": 2,
      "target": 52
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-\u0002B pathway were disrupted byL-theanine [128].",
      "key": "02f40f1008153554729f0b3644d0a0228de5067e2b40a1a70661015cb1db266642e5405679c20a215d329aa84e6a8fee5709a4979aec570299948094811b91cc",
      "line": 599,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 64
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-\u0002B pathway were disrupted byL-theanine [128].",
      "key": "5a557e7c94f257f79be33eb495fb61e1b791c27689c0110312ebeccd12c2f8876885cd520cbefac2571cb765e71f4eba3a5707542c622ce53ae3d4be69fb47c4",
      "line": 600,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 89
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Besides, extracellular signal-regulated kinase (ERK), p38 MAPK and NF-\u0002B pathway were disrupted byL-theanine [128].",
      "key": "e9883f9753db54d9ff211a55bf070b11fbe640d49a3b6be74e53a4f0d8f18e0d778c360e9dbc1cc0d544fad65ce690cd64b6b8532945c546c1123d203d140479",
      "line": 601,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The mitochondrial membrane potential, ROS and NO levels were down-regulated by 1,8-cineole in A\u0003 25-35-stimulated cells [250].",
      "key": "9a846f658b29217fd708cf06d7ad716eb06099bc913d82fdbb842f75b8fd094936a0ad08d5ec3ffd58d8cebd2cd185580d24728de221123be6110992af629f8d",
      "line": 606,
      "relation": "decreases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The mitochondrial membrane potential, ROS and NO levels were down-regulated by 1,8-cineole in A\u0003 25-35-stimulated cells [250].",
      "key": "914b8439449c842ddc6fa39f854136ab0454c0a9911b3e8c8bf434c4a5ec5bb83f86374dc0abeb6530319d57916906d35ce437320e007e69589639c8bd67a97a",
      "line": 607,
      "relation": "decreases",
      "source": 1,
      "target": 9
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-\u0005, IL-1\u0003 and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in A\u0003 25-35-induced cells [250].",
      "key": "461444def61b6bb903de48f6c79d01a8d3301d41a72db675f2cea024894f84dcb1991a29c56e58a7413cd4d80ed5e5dde694f118ee97c3a8891e1b017d02feba",
      "line": 614,
      "relation": "decreases",
      "source": 1,
      "target": 107
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-\u0005, IL-1\u0003 and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in A\u0003 25-35-induced cells [250].",
      "key": "a318ab3d3b16c060f3820c501624452eb38a22ffbad5e4db9fdfcb71d238d34e12c3e64d0406b236df0b63d4d83bee872f066b191d110485acc6525fd2ae0367",
      "line": 615,
      "relation": "decreases",
      "source": 1,
      "target": 85
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "The expression of pro-inﬂammatory cytokines such as TNF-\u0005, IL-1\u0003 and IL-6 were signiﬁcantly reduced by treatment of 1,8-cineole in A\u0003 25-35-induced cells [250].",
      "key": "3c357522925b5cf6d0b92117cc156f0773a205623972a1586b3af37537c0021f942b35d7dc5807890d46a8c429a71ff3bec9c07d5cf9cd287e105ab9ba08cd9e",
      "line": 616,
      "relation": "decreases",
      "source": 1,
      "target": 87
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-\u0002B was reduced by1,8-cineole [250].",
      "key": "4f983871ed2b189aca42e13c7565f7d3cd03f778a630fb9418178e64ac25b6367c8705c0fbd13d1d88956dd5263917bef85e6325ca99fe438c128d264df11ad6",
      "line": 621,
      "relation": "decreases",
      "source": 1,
      "target": 94
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-\u0002B was reduced by1,8-cineole [250].",
      "key": "1a67e8b1734b16c992f3cac2fb7bafdbb87ca6e003a48f97ff7071703dfd953de27587905558e3197d43f2c04b98729dcb09b41c6ebb7f269cce1febbc14d8c2",
      "line": 622,
      "relation": "decreases",
      "source": 1,
      "target": 96
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Further-more, the expression of NOS-2, COX2 and NF-\u0002B was reduced by1,8-cineole [250].",
      "key": "ea4829754eaacd4f72b061852478d4beb2fc7ba5d4dba9dff59f4293996664ffd981a7ef70daf407341b53e1c33630973df41646d3a6a98285976ea6ad78270f",
      "line": 623,
      "relation": "decreases",
      "source": 1,
      "target": 71
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Paeoniﬂorin improved memory impairments and lowered A\u0003 accumulation in APP/PS1 trans-genic mice [1].",
      "key": "e261fb149f922fcdb51f04f325cd94a3297595b5c5dbaf177c35504348ab7596e12cdc094db247426b64e02cfdeed0ab3e3718a2024ba87d1470d9ae99f9bc25",
      "line": 629,
      "relation": "increases",
      "source": 40,
      "target": 55
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "Paeoniﬂorin improved memory impairments and lowered A\u0003 accumulation in APP/PS1 trans-genic mice [1].",
      "key": "133a1b8d12fc5720e9ae71ca47bd8301163e1ecb41dbc1b7f04c187769128c9ef3285afb4d0da7b06c2e3b3f870483dc0105f764896b9ab50676412dfddebb9c",
      "line": 630,
      "relation": "decreases",
      "source": 40,
      "target": 26
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "53ba55aaa08d0684237e8416623196600b79cfcab8da394b22b6545cd494378ca3a391e5064e7e96d71295424ae4cfcd3e5ca15238271747fdad210b36898a87",
      "line": 637,
      "relation": "decreases",
      "source": 40,
      "target": 112
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "7b6e9c556a6117301b37e1c88b21ba049cd99230357068ee71f1513ce5a3ae78e95830fa7fc34c397ee91b27a8bbb39b540213707f0a2f43ce0f5490551028d2",
      "line": 638,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 40,
      "target": 66
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "acc34f2ae29688f7e8b360c1fd16a5c30c511e218f11d1d37a9ae018d82c464416783b78383579f123fb1b5fdc83914e1b54506254cef32a1db12b42cb163dd7",
      "line": 639,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 40,
      "target": 71
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "122fa5f743672f07a09e17905d2c96208f39032f43d8d4843504ef8b8e4017bd73fbd9dc08995b5869da506e90cff0241ee756f179022a03e9ebd297bdffa006",
      "line": 640,
      "relation": "decreases",
      "source": 40,
      "target": 47
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "9de3aef488fc2063d53d6e6efe4b209dbf927356afb885e11ec7955f6cc3628784bebb5b3022461d89ab0d7f820c5fa6a307d07e3382cd711f49184f17f45c36",
      "line": 641,
      "relation": "decreases",
      "source": 40,
      "target": 107
    },
    {
      "citation": {
        "authors": [
          "Efferth T",
          "Fischer N",
          "Seo EJ"
        ],
        "date": "2018-03-01",
        "first": "Seo EJ",
        "last": "Efferth T",
        "name": "Pharmacological research",
        "pages": "262-273",
        "reference": "29179999",
        "title": "Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "129"
      },
      "evidence": "It attenuated the development of AD by inhibiting glycogen synthase kinase 3 (GSK-3) and NF-\u0002B activation, and sup-pressing the NLRP3 inﬂammasome and cytokines such as TNF-\u0005and IL-1\u0003 [1].",
      "key": "ecf2ee5f04090fee80f93be4e6c4deea76bdee620fdea4e6643370a372f07b17e6a9f8e025f76106201d98d1555f8ca509479706b654139f2b49ac46516dbdbf",
      "line": 642,
      "relation": "decreases",
      "source": 40,
      "target": 85
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(+)-artemisinin\")",
      "function": "Abundance",
      "id": "949f6ba04a6f1e1aff1fe19cec84e554efee6faf246ece27a501160a5450f6e54fef0fb6f51756661e01a705f42e22dd7fc15157e4d8041f3e5703b3f560af0a",
      "name": "(+)-artemisinin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"1,8-cineole\")",
      "function": "Abundance",
      "id": "c546d3783b1e4126cb059adac47e5c0ae7232389be1c72e345188d87a48a11d4a292696fb85588dca217bac00f814a3889f3fe93758de3fd365035e0dda89de2",
      "name": "1,8-cineole",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"N(5)-ethyl-L-glutamine\")",
      "function": "Abundance",
      "id": "de982daad5f81c961820bafccf63a5dceae9ce80cd5e3a7c086ee548568a8e5b3bc884d3a0cd990afd8e1cbcaf5e8196b2c68b5517b536fb7bfeca92cbdff6bd",
      "name": "N(5)-ethyl-L-glutamine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"alpha-tocopherol\")",
      "function": "Abundance",
      "id": "51ba71f134b46a2829b9619c894194e4c3258de13d9f6a7bf45f8abec820627324ac08aed08686a4a99347f6c1b9bc6cc496648062a9a3e1e1c1427db2c56e54",
      "name": "alpha-tocopherol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "function": "Abundance",
      "id": "2ca2eb795438fe9e0f24c1e9d332717de5e344ddfee00ce8df89c5b901d85db5994d6ffd383e40a90bde264f33e75b220476b3de86c89f0658bf281c872f0bb6",
      "name": "amyloid-beta polypeptide 40",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "function": "Abundance",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13",
      "name": "amyloid-beta polypeptide 42",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"gallic acid\")",
      "function": "Abundance",
      "id": "72a01da10ed536b760fd7b1477888737a2a8ed432bb7c3ab9b75d01278be94c16a4d9200e4ccb01a303d730c342e231ded6574daa46fc0e446fa590d6750656b",
      "name": "gallic acid",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"methyl 3,5-di-O-caffeoyl quinate\")",
      "function": "Abundance",
      "id": "ff6150b47d33fd1eee8c9303f7565f7225e994cfb5786017cdda631695a8cc6c90270644df30b0d42390c815709fc3b66fcdd6b109ee3e3e4d859e2dd01c8f30",
      "name": "methyl 3,5-di-O-caffeoyl quinate",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "function": "Abundance",
      "id": "fd0dcffbd4e00c161d74c931890123439e35f86a92cbcf20c1efaed0bb8b8469434bbafd8364de8822b9af6368de418ed1728b1534bb8eeb47320d5a9c895548",
      "name": "nitric oxide",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin E2\")",
      "function": "Abundance",
      "id": "de6c0ca2910a5c497e43265ef19bc6e5efc51b7c8306b3ac09669c50e03d5b79ae674a12a1c14c66141c6abe24c505cf8efb93e75bc4d5b83579456da7301f28",
      "name": "prostaglandin E2",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "function": "Abundance",
      "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65",
      "name": "reactive oxygen species",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"vitamin D\")",
      "function": "Abundance",
      "id": "4cb28304abd27f9aa3d5190a7aba8907d8e7528ca09b0f4ffe001856a2a2e19c15ea1e88eda862ff179f8fbfd362135efe299ba4edd11a8f342b3b2d9db6d18d",
      "name": "vitamin D",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Anatabine)",
      "function": "Abundance",
      "id": "c77d4080804731f0ef07ad52ed2fbccdac5d02fb2620d8800d273e925feebcbf90b94a2399efeb42a91e65413550e0f713cd431329129e1cdd90329cae6b3ff6",
      "name": "Anatabine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Geniposide)",
      "function": "Abundance",
      "id": "8a5bd5cbc92f1ec932d72f28287b1db3cd78eb8bf6ad75e9e6f2d784009c187e93609b1fca1a537d2de42f7893733028366933460f555b4ad704f99f6350fe56",
      "name": "Geniposide",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:Salidroside)",
      "function": "Abundance",
      "id": "913c02ab5d23035dc768d42e384417f8ab68540437ae844dfaff0ea0cae565c191813364e6ef0429566ad2fd9acf08e7d2905b283201d2a0471dc18ff9f3de6d",
      "name": "Salidroside",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:acetylcholine)",
      "function": "Abundance",
      "id": "bae5841bb74f1e9eb73cd433cda657927031217c24e17f21bb2975128d1d9be4dc899448ede71d9aa18224145a1681b90b33287454eabf938f405bc1b8894b62",
      "name": "acetylcholine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:berberine)",
      "function": "Abundance",
      "id": "e57e7808372e142d1dba445b83ec643c6330f0d1bd2804c0331e332e1e26433cc8b8c9f47fa38a72ca59b1ad3651943329349f590ed90906a4c558eb9c0109ff",
      "name": "berberine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:curcumin)",
      "function": "Abundance",
      "id": "a784cb1e1965d09b2812ceaada10e172836399f6b72ec8154a36346d212255f49d8ae319b42578ea1c29fe7b4f04e3396e963011eb98b928bfd624dfd7fa8787",
      "name": "curcumin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:galanthamine)",
      "function": "Abundance",
      "id": "829d639ffa1b9cf0dc884553079510b093dde8971a129c58afff24ea1d1103f0db214945577b66dc941db450715ecdfe7951a8498afafb02cb1653b60845fc57",
      "name": "galanthamine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:genistein)",
      "function": "Abundance",
      "id": "06c0c5690741680b20f26d0526d1f231e119a814ce6a1ac4f064c9c9b504b737f1df6ef95c231dd40aa4b6b02e91df3dacbc2aa1c419c1ca588e49458be812c8",
      "name": "genistein",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:lycopene)",
      "function": "Abundance",
      "id": "10487879ec1607ecfa62113e40ceb5df0a24312545aad50f4ef1ca12b2b4b5394f98df7a036bffc2a8639d707be464deca164528de0389fbccfd51fe6f5e5be6",
      "name": "lycopene",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:nitrotyrosine)",
      "function": "Abundance",
      "id": "8a2293a9a0d1683a7619243ace3280d36066ebc7f9c477ed1286357a7aa1beb4e09663b5fa30f9583aaa036e6ce776f457ad36d9076d2d7f4bbba21dd136dbce",
      "name": "nitrotyrosine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:oridonin)",
      "function": "Abundance",
      "id": "a1f47045c20ffabcdc659c5f07259c692a73d266c387b2b5fd67dcfa7d36126e940bfda21573e134f2257ab61267cc7c3e87176fa6fc357a2afbef97b2a4114e",
      "name": "oridonin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:pterostilbene)",
      "function": "Abundance",
      "id": "b1a3cf0ffd3bebfb2520cb43122226c79fbd32332bfcd7605711e8b35ac2764dad08193483e500b721c0ce25362756beaf9fde355168dff44563ae370e533913",
      "name": "pterostilbene",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:resveratrol)",
      "function": "Abundance",
      "id": "545daa8c15363de2760fcbff1fa1c472c83bfc4fa06d5cfaaaf1259fab8d6ac783ae0bdf7ae00fd6f6e0c5c7541242453b6423c657fbd723321fbcfb5bf953f7",
      "name": "resveratrol",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta aggregates\")",
      "function": "Abundance",
      "id": "fcc150a975d4e4470c5e429ea32220fdb47e51ef258188552e58fa57f7095a6257914f165d06469ed45b6a1bccc8149eacc0ad9fdf9248a2ac69db715285c72a",
      "name": "amyloid-beta aggregates",
      "namespace": "CONSO"
    },
    {
      "bel": "a(MESH:\"Nissl Bodies\")",
      "function": "Abundance",
      "id": "bb6a91b5e7120b987cdad566771faecaa2bd21ad2b9374a29a8de3e92d5bc382532a7cfcf6b1ad6fd845737cbcbde4732a5ce081fe2fc0612b46ec3d484e7c93",
      "name": "Nissl Bodies",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "function": "Abundance",
      "id": "b212e0151b8087a85aaf17315ce4d0ca06e7fa2700f3e41b10ea54a20d2484f11b545e768089b4d2b117a4feb6c7438ffd569bfaecfc5b5667807e6c2d637f93",
      "name": "Cytokines",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:DNA)",
      "function": "Abundance",
      "id": "95d84a361d8539bd7b9511d6113341bc4cb9bb20d67dc89a1636df74c9ef88fac8591c3cad7030c550c7ac43c7827b8a6f9cc771226d04b7facd72eb3f4d1b32",
      "name": "DNA",
      "namespace": "MESH"
    },
    {
      "bel": "a(MESH:Interleukins)",
      "function": "Abundance",
      "id": "76334980172086b1c84a609bd3ff3eb09636318347f73c299de8046296b34d9ff247929714dbdfe9651849d17bf66d2d0b2adce121135b0c75213f97cfffa6a8",
      "name": "Interleukins",
      "namespace": "MESH"
    },
    {
      "bel": "a(PUBCHEM:102336202)",
      "function": "Abundance",
      "id": "22b3505296bcb1032910511bd833340d15ae015918f0c185c2e4df77ac602fd1cf00d5f9ac814de847b9e261a970e010a32c47199227b9eade8b0f8afdd7e1c5",
      "name": "102336202",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:14193399)",
      "function": "Abundance",
      "id": "9b6d89eb2be6ef0589d772adb8f1f1344d97e67075af8b69400553197194399559a798fbd9160f7c2057bb4b0231973253e0c65faf624b7327d50a6085d8df3a",
      "name": "14193399",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:155160)",
      "function": "Abundance",
      "id": "8503cb86cc685af57b7ef0ed987c9a4898c611278e11778ba5a3d1d087def9ca2683f2d7d6032a6d3d676e5c906fedd5b5ed4afa7d0efb09198ceee1faa1d8c7",
      "name": "155160",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:164676)",
      "function": "Abundance",
      "id": "494eb76f00b5cdb63e8638e421d32d54fc6c1c4ea880c3b54039d2a1f059a36d409237f58fb2f88a43a070c2a0dc4527d519537465df0dc7c7c2e1e45bd03bac",
      "name": "164676",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:24721561)",
      "function": "Abundance",
      "id": "7821beefab9120c1f4e16ee171dffc8d659c93e0fb1d49b7f5b7cc4f35dcd75210744a3ab80027f79dbd56e77fdd112fc32bf1b573fcdaae5feb5876759e537d",
      "name": "24721561",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:3086007)",
      "function": "Abundance",
      "id": "e3d913a8521f1850ed136dc1c147ac620c4b78ca3afd37ab4e388ac3247538756b93821761ededf7e8f50e2b8ac3a04c59d170cdbc65a6a35be47e0c2178f749",
      "name": "3086007",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:440312)",
      "function": "Abundance",
      "id": "e8c55ea5970e3e60d688d37b03b6efb009452959ded1b8cfc4ce0a6ffdc110aba4464b10fb55a0824633b2f8388f35bddb3680b89e8f732a496401d3cb9a1dd7",
      "name": "440312",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:441921)",
      "function": "Abundance",
      "id": "9f0302e01cfb1a8dd31a6ab0e5b37ef67f7e2e013757589f58608979f94fec8de4412423687452cf43cfdea3cbc0f6964b38fc858deab1559b56a44cd56aac7f",
      "name": "441921",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:441923)",
      "function": "Abundance",
      "id": "50b370a5d821949ac486bde5b920858729f7ca1faeb8c81598d1e28c697b35e937376408700b547c1baeb7a9077b9c1c6c41e8fbe21f62b7a59e0a3f56291301",
      "name": "441923",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:442534)",
      "function": "Abundance",
      "id": "b3acb79bcc8a10d2b2dcfd502294d342bdc77fcb18d8ec8c4d83a4b9baffc82e97e04f8666b1cb116765719391c2e8f28e1219db9adc9e3293d7534111aa0e71",
      "name": "442534",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:444795)",
      "function": "Abundance",
      "id": "c81cd8b512e19541ee4133272bf3b136c8d0e6ee4c05597de9fd75b7526a8dbd1a2cc3d1bdf0ca868f57a634869efa90481ab3a47469836da02bd7a10defc16f",
      "name": "444795",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:44584733)",
      "function": "Abundance",
      "id": "ae2582b922535bd9b4129c63370741aa32d7c111b1b1a92c5a8a87b5827deea2be5be3a6e6c653931ee38e85b23ecb2953551f03b77cb65ebc49a8cca1c14b92",
      "name": "44584733",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:45270574)",
      "function": "Abundance",
      "id": "cd71dd578924b152a0ec587ae826f133fe56d1c3aed2ebf9d1379c397dbf9d191bbb9c7fc86a524f5b9cc392bfb20d470205966d6f4464412683ee189e0b1294",
      "name": "45270574",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:73078)",
      "function": "Abundance",
      "id": "84960740f69ae67866a0e95e29cae0fa489b15e0dd67fd6e5ab20d974ab2ffcb693d72c34d688d0566b6c74c35a78a0624cdc5b13124d92684cc3a643901e259",
      "name": "73078",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "a(PUBCHEM:9918693)",
      "function": "Abundance",
      "id": "874fcca0a5eccda4e52d266717ae596bf52179e2ff7b83c1c18db1a879e7417ea4b47f9bd6b7b3b8a448da1e650768bfd974033c1de2ad9f49f483106f49e66f",
      "name": "9918693",
      "namespace": "PUBCHEM"
    },
    {
      "bel": "bp(GO:\"NIK/NF-kappaB signaling\")",
      "function": "BiologicalProcess",
      "id": "03697f121a26abd135ba54aa98c3b94e2b0ce3126eaeb45822a256e87ada060c314ca017fcb070d1000678dc7be8c69f0e0fe8409e8d923976c9c6d7f21f390a",
      "name": "NIK/NF-kappaB signaling",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"NLRP3 inflammasome complex assembly\")",
      "function": "BiologicalProcess",
      "id": "cc2f9b2af91e9f34f361b9e508b2dbefa39f69a334a888632186acfaec9772d97bf4fe65a8080344dec4350329a0b2407169f7b2a37ae91db2396cdccff61075",
      "name": "NLRP3 inflammasome complex assembly",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254",
      "name": "apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"glial cell activation\")",
      "function": "BiologicalProcess",
      "id": "81575e3bbea20146818dda88138225545873161acfb21d6fd9d2c432e942c50c1882d001826d814fd0a5bcee53a65b5805f50dc1230a6b64829dbc7c4651d14d",
      "name": "glial cell activation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "function": "BiologicalProcess",
      "id": "422dfc2db00b1d942862470cbabe1e8312bf97b25050190db5ae19636adae95f4fa18c512574526825bd377b16c2278899435eb759e951ba850ad476e14f9900",
      "name": "inflammatory response",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "function": "BiologicalProcess",
      "id": "9e9682b78aa06bbcb9dae35006f6da468e11928c000097001cd665b1bedf3c75ef887ecd7781ef3c545cafb3780cb7afabec9bfc70e14a48149d8adee8502981",
      "name": "microglial cell activation",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "function": "BiologicalProcess",
      "id": "ad7c90f2bc746a5118759fd1c8857478c02207d574a26faaac9d6e4d6fa4661d8d87446139db0024a4011aae26027d3cabdfba663aec0ac0a8242868efb81dcd",
      "name": "neuron death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:cognition)",
      "function": "BiologicalProcess",
      "id": "8d73f2caa1c473289d5f37cbdd4ad391a120cdbdf2356b373070c2a7b2bc0c785eaa620782fa2dd947c666100f0a169e81f35864f359cadf3e1550962fcc4127",
      "name": "cognition",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:learning)",
      "function": "BiologicalProcess",
      "id": "24fec79fe31de63921d3028dd6ce5e335372d8d221877724830f05136d6c879daa7585768231b87272f0ebb8a7f6038f1aabb8785a626cca0c95b33018cc1633",
      "name": "learning",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:memory)",
      "function": "BiologicalProcess",
      "id": "87795d00588bdf77d28229ad379d58f00922f6339902a803d0672cc15e669269f8fe50785b2851e1e82046f4e1e49920534ec68c0b6911bea5a1b838dbc999cd",
      "name": "memory",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(CHEBI:galanthamine), p(FPLX:CHRN))",
      "function": "Complex",
      "id": "a62ef1e129b46ff527e8ca5275864c456539cedc529216b6addb60ecf5542d9b04a526ad2d3e83fe0ad7a6fb97229630850da119ea5c0f84465ddec199ec1862",
      "members": [
        {
          "bel": "a(CHEBI:galanthamine)",
          "function": "Abundance",
          "id": "829d639ffa1b9cf0dc884553079510b093dde8971a129c58afff24ea1d1103f0db214945577b66dc941db450715ecdfe7951a8498afafb02cb1653b60845fc57",
          "name": "galanthamine",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(FPLX:CHRN)",
          "function": "Protein",
          "id": "2d70e5187bc44ed8ee9d64163e62e209522d576460d28ee8c947c1bda63c6d1f2233f349d74a2bae45ed4d59044c0e1be1f56ea9944bc08740426eb8678d6df5",
          "name": "CHRN",
          "namespace": "FPLX"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:DNA), p(FPLX:NFkappaB))",
      "function": "Complex",
      "id": "26aca6f9549e50e19a26e90455276dcf8416c4963bb8f218ad0fdd662ca30646b64491f931e62319684ab3555ec0b59233fe3667efe9594b273d6538298f9049",
      "members": [
        {
          "bel": "a(MESH:DNA)",
          "function": "Abundance",
          "id": "95d84a361d8539bd7b9511d6113341bc4cb9bb20d67dc89a1636df74c9ef88fac8591c3cad7030c550c7ac43c7827b8a6f9cc771226d04b7facd72eb3f4d1b32",
          "name": "DNA",
          "namespace": "MESH"
        },
        {
          "bel": "p(FPLX:NFkappaB)",
          "function": "Protein",
          "id": "a76f3010d13c4b506ba95e6e6bef897dc400ea1bad5f8288ce4b084f2b57f9e7aa59f5146eff656ed56a6d2077d5907c41cbd4539f26d63411b79ffe7179e54a",
          "name": "NFkappaB",
          "namespace": "FPLX"
        }
      ]
    },
    {
      "bel": "p(FPLX:\"Gamma_secretase\")",
      "function": "Protein",
      "id": "99713174fec183dbce7064ce1acd26970ee41a511f23df4d371fd5278c633824e492dd22684d4b64d57643ad528d90992950c5a00b1bc6870245e83c2953a132",
      "name": "Gamma_secretase",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"IKK_complex\")",
      "function": "Protein",
      "id": "94167d3ca8305f0df7910939f125234d0d8fcb20497510c3aefb088e8e0ccc50bd681033a627a16ccf3ef1ad533a62fe56437afcb1e0b0aa3d68d52aa40044d7",
      "name": "IKK_complex",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:\"IKK_complex\", pmod(Ph))",
      "function": "Protein",
      "id": "d20bf49634b1e869ebc0debeeacdc29efafe8f23738a001005e176b4da9ddc20ca65c61291bd240c7c24e3f5d2a466dd399ecbd3539495b1d7783c80805f48be",
      "name": "IKK_complex",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:\"NADPH_oxidase\")",
      "function": "Protein",
      "id": "cfc69dfe147918b64aad63b8b477217ba22b9a62f87bb042f84768dc7e17332d1cb95b8599b1a046c7f586cc11674aa71fd62a28916012a52b372a5842685263",
      "name": "NADPH_oxidase",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:AKT)",
      "function": "Protein",
      "id": "3263678a1e320013081e7134e7e64e91b2c66e6fbd10dd7fe4fd282cf0cc3ba29b5cacb5e8eb0a8ac0a194f73b80dabcea5465b0fec5b044290b259ba889cef1",
      "name": "AKT",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:CHRN)",
      "function": "Protein",
      "id": "2d70e5187bc44ed8ee9d64163e62e209522d576460d28ee8c947c1bda63c6d1f2233f349d74a2bae45ed4d59044c0e1be1f56ea9944bc08740426eb8678d6df5",
      "name": "CHRN",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:ERK)",
      "function": "Protein",
      "id": "d47253e059ce1284f4d182a53246f4d993b24c69ceb8bee74fb2a12d7d07c4a0ea65603dbb5d741283f27159ddf01ff72e2c045c05128734b83ba3ef067837b4",
      "name": "ERK",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:ERK, pmod(Ph))",
      "function": "Protein",
      "id": "c5ed40d03c26ff2cead63f468094e0539b55b94d81228e1edbc704f621326ed2b3e8b68eb8b1764548f737183a2d4f8d75120062abf7908e6a7d2dbe0ce2ce6c",
      "name": "ERK",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:GSK3)",
      "function": "Protein",
      "id": "9347360e58cdec3f018064a4eae9a0cf197c9015fadd80cad6dc56b240cdfc8314a61b84f05cab89c9d7443d29cf27d675faf92154227319f92956f11c74c1bb",
      "name": "GSK3",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:IKB)",
      "function": "Protein",
      "id": "34ba30479764e6d9eed7d279a1383932fbca9f3b65942b606f3b37a0d4b98a0bce9557ca9d5bd1bcda62f1f839c48d4ab9f1d1de5cc34345e0646cbe90349643",
      "name": "IKB",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:JNK)",
      "function": "Protein",
      "id": "a9ed6db257ad5286099b1c787f20b6023ae9588e34100f98373865a084224f3815988fd9eafd8a85f974c668ef8c48bad8bee8de58c6e414fc8b084d8d066d6d",
      "name": "JNK",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:JNK, pmod(Ph))",
      "function": "Protein",
      "id": "3b137982ae4b3040d5c26783fa43b51ac6b5dbb59c8146b59170d1026a40748e274e2fe0a7af9d2057cab5a0af0886623c51764d4ac5f3b12ca78f778ce1c929",
      "name": "JNK",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:MYST)",
      "function": "Protein",
      "id": "c71e3eb5e5a3cd6da24fd736188e5f8738000304755df9e18a633304d3b18345916e72c8006092c1b1499ee0ff42fb59ab5a0e02b193b7b6eacd7d05950bfabd",
      "name": "MYST",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:NFkappaB)",
      "function": "Protein",
      "id": "a76f3010d13c4b506ba95e6e6bef897dc400ea1bad5f8288ce4b084f2b57f9e7aa59f5146eff656ed56a6d2077d5907c41cbd4539f26d63411b79ffe7179e54a",
      "name": "NFkappaB",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:NFkappaB, pmod(Ph))",
      "function": "Protein",
      "id": "d0f8ceb48514f70eaa543a89348899f5f38b7d122e33d4edeece1f4987dce39e22dadf4ee9139f2d2930bd79c0150a7391756544864ba8aa51d2d584674d2544",
      "name": "NFkappaB",
      "namespace": "FPLX",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(FPLX:PKC)",
      "function": "Protein",
      "id": "12137fadfdc5eb838cd33edabcf36ac0b775609d7303971d52755e1335928a559973fe26211ce3ac9a8599ee75c77a978b44d1d7114437a922a8911d9016aceb",
      "name": "PKC",
      "namespace": "FPLX"
    },
    {
      "bel": "p(FPLX:SOD)",
      "function": "Protein",
      "id": "a15a55de3bf124627aabcd66e182df4019bd37a501572902da3ccb8f2625a59a2939f14039ca5c4e05991415eed2d8f72c19f9c5782d10e56d6f5011f8631646",
      "name": "SOD",
      "namespace": "FPLX"
    },
    {
      "bel": "p(HGNC:ACHE)",
      "function": "Protein",
      "id": "9d3104b5d47c472fac8109aed790de48a5955d80c72a1ca46580350b0d6c41e96ee75cb1cb868657d107abf241c10c81b1c892d4eee5a68f558f78cd14ca802f",
      "name": "ACHE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CHUK)",
      "function": "Protein",
      "id": "48d5f4d56eddd155ff7a85345988764054b91ceae34dc707e52ddbb4b528a41e2c51ec0bf95ff60c891aa31e7aea3647ea906ddc2d36731187e31adee9875475",
      "name": "CHUK",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CXCL8)",
      "function": "Protein",
      "id": "1d43bb6142e5802710652980dca32f0b5ae0bf401e5d279f80368982ffd1ac2adb0d667cc1170852072dd6a82b8fcfabaf1ed9869135585b804d73f99084a667",
      "name": "CXCL8",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GFAP)",
      "function": "Protein",
      "id": "770dc5af3e4196536cabe720b408d7b24bb48c25eaa89cca048be9e87bed6118fbd749fb5c0b8b7814422fb430d364ec871f487b806b480765332568170c04b5",
      "name": "GFAP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:HMOX1)",
      "function": "Protein",
      "id": "c4981e9d3903b58471e749e0a1e38277c2729152c5582926243649d5c266ea44d831061cf916b7c6334634d357628b16c015a7ce07c97084f06b2c3f3cc94d5c",
      "name": "HMOX1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IFNB1)",
      "function": "Protein",
      "id": "1bfd623070c68c26f9effc55f735ad89b3a053720cbe751136139dfe0fb4e3f81ca8953d5c4f16c31547506523952487e024af92ccf52979267f3b18a90cf5bc",
      "name": "IFNB1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IKBKB)",
      "function": "Protein",
      "id": "28e5502b7aa15e90a0c64acb67a696a6fc3adacda266866a25c5252f6624d886959cbf1cd70f5fc86e53b14a974040690063553547157b3c41e227567d81609e",
      "name": "IKBKB",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL12B)",
      "function": "Protein",
      "id": "fc3f670d02ff75d28192f3a67521a221f0188c46b2ad3fd2dc64716052eeba966070b4979511222808c65b1af2c8f3ccc5e94ef15162625a4f3ac00197bdc3fa",
      "name": "IL12B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL1A)",
      "function": "Protein",
      "id": "caf4a8115efb276226bde9ed84ebbfdbce1d6b839d5e56ed874a52d7bf452cfc268da490b2b873ad4984da520b65d2e8776e7f411fc740e619f94b36a5764b54",
      "name": "IL1A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "function": "Protein",
      "id": "bd7736973dc00dadc09dff75214ff05344d2e9b6dfbc09a364f08b7cae84142149292551bd60d5addd6130e971c2ccd4c73b963ad918ad9b0a418b94e5a30cfd",
      "name": "IL1B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL2)",
      "function": "Protein",
      "id": "3b9efc5a25b0e56982de6f231d558a8f5c887d715d21a3927a14b9d4ca70050a4313ca08ae497ab0871709396fbd7642f0d0fadef88bd48cd443605a9fc230fc",
      "name": "IL2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL6)",
      "function": "Protein",
      "id": "51885c84a128c79b3473fbff464c7f04886821c78a7b0097d2e9fa942742f7586bf06c4fcce3776b98a284d6d0f0c669f1e6b0a029047df3f9f1549abf57ecba",
      "name": "IL6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:LOX)",
      "function": "Protein",
      "id": "3c0b987a6981b2848f0bd4c0375d987c2e004f80ee6eeec8aa622cd424f0b0d13484aee5bc3043f7f2062ff0ddb46c5c2c989bd18fd9c55bd9584e2cf94620a4",
      "name": "LOX",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPK14)",
      "function": "Protein",
      "id": "7c10ba4aa52bc8cb24fca9be53229a6eafa3cf7979169443f5748eac1db12270556317043e9ffdd7e8ad9225bf8825aa187b298f8566ac3c3e8ae485a0ce8656",
      "name": "MAPK14",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPK14, pmod(Ph))",
      "function": "Protein",
      "id": "20eb5f10d76218823a521c758ba066268672285494ed281bee3114907acf24960dc07f9ce5cef01c9c2bcd5a49b83f806e81cff34b84ea096b35eb570f5c5de8",
      "name": "MAPK14",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MMP2)",
      "function": "Protein",
      "id": "34870a1cc27321004b2000a39f1f5114ed7aeaf2c939e9883ca6efb42490e30644274705c14d5694c3ce84cf38c0824d8c1c609e1c794efa7f1d441be6c8002b",
      "name": "MMP2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NFKBIA)",
      "function": "Protein",
      "id": "9b4bb952ac56939715566b2be0e9e32837d1688e51c453a2e2d00d51fb4efd6b25a3e42654c40166b33acc42b405f24eeb2dacff3aac84d496bae22778f98e45",
      "name": "NFKBIA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NFKBIA, pmod(Ph))",
      "function": "Protein",
      "id": "f30d9a5cc91e0afa7cd38e51f85ce5d61ada22b5d8e7ccb53f2fef2f5839f79cf655667e772859fdb72181f4676c9102589fda07307fe90620c5fba00c2ccb6a",
      "name": "NFKBIA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:NOS2)",
      "function": "Protein",
      "id": "b247a388978f9811ff9da74a67b691a4ded9ea5959a19112a001bd26f7a0c52b133b4937a2786b12f1c935f618a7f249b3f20beb200db000b10d85ebd06bf0ef",
      "name": "NOS2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PPARA)",
      "function": "Protein",
      "id": "306c33d81cf5ce449c1bc45ac449375c3cecd4e7bf756ed9e71e7cf1760f7bbacf5c762513cc70d5488d96c938f70daf206a3dc684c810be0ddacb71d8402ae6",
      "name": "PPARA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:PTGS2)",
      "function": "Protein",
      "id": "27d20a84fc69f69703d772c4c3f352ba40db277dca1150acf8bb6a1c86d031577910da7f00aed7d06e071f07c971fc42117b516fabfd7538628f4bcbe3e689df",
      "name": "PTGS2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RBFOX3)",
      "function": "Protein",
      "id": "e0471d0cb2735f99a9ef35d9a7fad947a64ae5366deaadc3bb5d65a7cd22f5a3b6ab82850ae12a696e2239694ae5cda1d3ffd084786b4598a90d3613dab31d26",
      "name": "RBFOX3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RELA)",
      "function": "Protein",
      "id": "02493376083b06f6044a237f4e756f227621391970d2c53693da442582176f53d992abe2f0fd0b28f8a305ab5f3429be4b4d20bd7fd4302ae88cf1eb87fe7e40",
      "name": "RELA",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ac))",
      "function": "Protein",
      "id": "a49e1aa3a40b4bb9d4039eaa41175c6f701a614dfbb42899f40a84b3950380ad13cacb409f20259b6ec133aeb36955b3a4f97710dfbb8347b75efdeb2b4d14cc",
      "name": "RELA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ac",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ph))",
      "function": "Protein",
      "id": "d51b9a8eb62ec08dc863472ef97b53eab28965cccd38adc932c625c25bbe0a563c50d39c467cb8d3bef104cab2430c5701227bbd62143b608a4a5d4be54c25bc",
      "name": "RELA",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:STAT1)",
      "function": "Protein",
      "id": "c884644a6d2aaea956f984f31cb5b77ba4d26ff00bf4d7dfc977ef1842d7fd8378c42b826ef873ce97bac7999da2171beeb1a51f5d7a4d113eb0208abf94ca92",
      "name": "STAT1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:STAT1, pmod(Ph))",
      "function": "Protein",
      "id": "ac5f972d416d4fe503b379ea9248d2f78b485749eb7ddbdd84c842e5e86cd69e0e4a45c09f0c3d042ce14ffc69a8c982e35a37dadbb4a42060b52f2fdd3fe802",
      "name": "STAT1",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:STAT3)",
      "function": "Protein",
      "id": "3127bcd18ece964c797c6ae9fcf716d99ad750c12e3f8121f817efbbedc60af9639294ab059c32ef6101cef3ccd9abc934d90dc7ccdbe6dc3604773782f7bf97",
      "name": "STAT3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:STAT3, pmod(Ph))",
      "function": "Protein",
      "id": "e77397464fb83748a7286fed66311fda660971f8d0f47f6e1290ea5f6857bdf68d361fd34f0055467a45dd0e21d8008bba9648e146ffd83670ee544b04bcf8d4",
      "name": "STAT3",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:TLR3)",
      "function": "Protein",
      "id": "228221b9ec695d421032abaa70cc2b55769293cc196ee804feeffd13105f261966eaae6ce7b7a5a4040c1f03aea1c87775ab0c170e3b3d5598ac7dc732fd3c82",
      "name": "TLR3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TLR4)",
      "function": "Protein",
      "id": "78baff0fa37f42a32cb911fcb85a347d217c0cb39fc58b19343a2a831d87febb268c4e159670cd621d3a7e29526bc3acfb79ac387aadea33a00624d7024e6701",
      "name": "TLR4",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TNF)",
      "function": "Protein",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d",
      "name": "TNF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TRAF6)",
      "function": "Protein",
      "id": "93077c10b7d180a177ac1f6def74fadeacc040afdc440759ada610deb14819e8925b37b1bace1c51cbca916405edfd8e210422aa427ba9fef46b14fa71449be7",
      "name": "TRAF6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TXN)",
      "function": "Protein",
      "id": "c74df5c537905ffd876f78a5486f1338b0a50a0947018608faa96b33a27f8d7b26c7a1acc51352a47c44d6be7a9f5e6df99b6b15d6eb78c2a22b6180f2b778ef",
      "name": "TXN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TXNIP)",
      "function": "Protein",
      "id": "d4d32935736c391c7106462bda4a7af5d8f58f680b65071d8320984495c54ba7817e693bc215d73d9a6a84a7c64387633e61026058a2e85e68266e34bfc8d683",
      "name": "TXNIP",
      "namespace": "HGNC"
    },
    {
      "bel": "path(HP:Neurodegeneration)",
      "function": "Pathology",
      "id": "147561abc7f6701abebffd45f44916b712f900d63acea6c80bb945bee3908e728bbe60dd1b63ce6c6833ee03a88f0537ad03e5da7f67e71176d2f91aad08f8ac",
      "name": "Neurodegeneration",
      "namespace": "HP"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "function": "Pathology",
      "id": "00f72839b5d655cb4cb088b0eb8874bd406284d98a2afd0bdd73de0a34adb78af374b0eb26990387f41d3b41cda0e32c1b5ff5f86ed63d0fdc841bac17865541",
      "name": "Alzheimer Disease",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Oxidative Stress\")",
      "function": "Pathology",
      "id": "b6f3383d4577b7ffb283f413a60e49c2f8226fe39c6edaf2b736361a5b4736b32b9a04bf41293e96599630d35eb5d897dbfda02cf25fd3c75122f5f0f37243ed",
      "name": "Oxidative Stress",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Spatial Learning\")",
      "function": "Pathology",
      "id": "211fd251c25349853a592b788437a1aa0fe1602f377e94c9e69815a2a9f82bb978e86febde798f0201920212b625fdde1919ddc54014881c2255cb8c56ba7057",
      "name": "Spatial Learning",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "function": "Pathology",
      "id": "7617bc77b1deb949824e3cb1b4d2c858cd784ace0d2c41934e19bdeb43b399553629ec153ef25e9e2c80d2389dfc60de193a290e2fb966544d5769aba98f1358",
      "name": "Spatial Memory",
      "namespace": "MESH"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "function": "Pathology",
      "id": "3196cc4c6a20279c822cae925a9b271d0224f2c8d468e3069a3ee460662be286b61db2f144c550686a9c624e58af4ffa7570f4f2384e1cb8ee40496f8cb3fa5e",
      "name": "Inflammation",
      "namespace": "MESH"
    },
    {
      "bel": "r(HGNC:IL4)",
      "function": "RNA",
      "id": "9172b147d5f90b3c03ab036642028424dcfb607ec556fd0e27d8112a0d6636243a82910f3dc6b3bf36ef5efd6f5c81c147c145294c28008f82e2d535b1c52353",
      "name": "IL4",
      "namespace": "HGNC"
    },
    {
      "bel": "r(HGNC:TLR3)",
      "function": "RNA",
      "id": "a5bb9f19d2a32d163b737a8221f9546144baf5f43d9ad2edc448f8105b16ae1f96323e1124d1dc8862018ed5048bac23f082f7941e5444511ed6bcae6b1da2a8",
      "name": "TLR3",
      "namespace": "HGNC"
    },
    {
      "bel": "r(HGNC:TLR4)",
      "function": "RNA",
      "id": "810c004034ff8744b60aed22727b9d3fdfa82c4ba12edc3076fdbd6aaa60821553e99dd830351de40832355b9dcd3a1c62adc385c7ab18bdbeb0f288c249668c",
      "name": "TLR4",
      "namespace": "HGNC"
    },
    {
      "bel": "r(HGNC:TRAF6)",
      "function": "RNA",
      "id": "0ffc7ccf7d86ac54a8d646fbf2eee10b3d2d54656750dd5c48e765538f4cc7e22484fc9406d31cfada6a7d6855e7a5b8b5b7896f1d849ebe2366f1fd44f895c6",
      "name": "TRAF6",
      "namespace": "HGNC"
    }
  ]
}